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ABSTRACT 
 
Stress signals are often sensed  by membrane-bound proteins which translate signals into the 
chemical modification of molecules, most notably protein kinases. These kinases, in turn, 
transmit the decoded  message through a cascade of sequential phosphorylation events to 
specific recipient transcription  complexes which activate the appropriate gene expression 
profile.  
 
One of the best known transcription factors targeted  by stress signals is the AP-1 family 
member c-Jun which is essential for cellular adaptation to many environmental changes and 
oncogenic transformation . The specificity of the c-Jun-mediated  biological response is 
provided  by the assembly of d iverse c-Jun-containing complexes, determined by d istinct 
d imerization partners, post-translational modifications and availability of regulatory factors. 
Hence, upon a specific signal, only a small subset of all potential targets is controlled  by  Jun 
proteins in a particular cell type, depicting c-Jun as a multitasking, yet strictly regulated 
factor. 
 
In this study, I have identified  the nucleolar  protein AATF as a novel regulator of c-Jun 
transcriptional activity. AATF is able to activate c-Jun in a JNK-independent manner, 
suggesting an involvement of AATF in the poorly understood phosphorylation-independent 
functions of c-Jun. Moreover, I provide evidence that AATF is confined  to the nucleolus at 
normal growth conditions and that d istinct stimuli result in its redistribution into the 
nucleoplasm where AATF is able to promote c-Jun activity. Importantly, I show that the 
AATF-mediated potentiation of c-Jun transcriptional activation leads to a prominent increase 
in apoptosis, likely mediated  by the induction of the proapoptotic genes FasL and  Tnf-α. My 
results are in line with current hypothesis suggesting that the strength of the stress signal 
determines the amplitude and intensity of the activation of the c-Jun response, in which a 
transient activation  may be associated  with a suppression of the UV-induced cell death by 
inducing cell cycle arrest, whereas prolonged  c-Jun activation triggers apoptosis. 
 
In parallel, I further characterized  the Cdk5/ p35 signaling complex previously identified  in 
our laboratory as an essential determinant of myoblast d ifferentiation. I identified  the 
atypical PKCξ  as an upstream regulator of the Cdk5/ p 35 complex during myoblast 
d ifferentiation and show that the cleavage and activation of the Cdk5 regulator p35 is of 
physiological relevance for the differentiation process and dependent on PKCξ  activity . I 
show that upon induction of differentiation PKCξ  phosphorylates p35 on serine 33 and that 
this phosphorylation is necessary to allow the calpain -mediated  cleavage of p35 and the 
consequent increase in Cdk5 activity. Finally, PKCξ  phosphorylates also calpain during 
myoblast d ifferentiation , suggesting that PKCξ  functions both by turning p35 into a calpain 
cleavage-permissive form and by boosting calpain activity. 
In summary, this PhD thesis expands the understanding of the regulatory mechanisms 
governing c-Jun transcriptional activity and c-Jun dependent apoptosis identifying AATF as 
a key determinant. Moreover, this work provides new perspective for the function of the 
Cdk5/ p35 complex during myoblast d ifferentiation and identifies PKCξ  as an upstream 
regulator of Cdk5 activity and of myoblast d ifferentiation. 
Abstract
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INTRODUCTION 
 
Physical or chemical factors which change the existent equilibrium  of a cell induce stress 
responses which aim at restoring cellular homeostasis. In a single yeast cell, stress responses 
induce a change in mating types which generate d iversity by sporulation. This process is 
mediated  by stress-activated  kinases, including stress-activated  protein kinase/ jun kinase 
(SAPK/ JNK), p38 mitogen activated  protein kinase (p38 MAPK), extracellular response 
kinase (ERK)5, AMP-dependent kinase (AMPK), and  Janus kinase (JAK). In mammals, 
homologous pathways regulate stress responses and are activated  by many common stress 
inducers such as oxygen perturbation, serum starvation, cytokines and  hyperosmolar stress, 
all of which induce cell cycle arrest and  are followed upon persistent stress by either 
d ifferentiation or cell death. Interestingly, many aspects of both cell d ifferentiation and cell 
death are controlled  by common molecular effectors. For example, both apoptosis and  
d ifferentiation use caspases, cysteine aspartate proteases which cleave and degrade proteins 
to allow morphological changes necessary for the formation of a d ifferentiated  and highly 
specialized  cell or to accomplish the regulated  removal of a damaged cell. 
 
The proper sensing and response to stress is necessary for a successful strategy in survival 
and  readjustment of cellular homeostasis. The strategy of choice can d iffer between a 
unicellular and  a multicellular organism, as an apoptotic response may be advantageous for 
a cell in a multicellular organism but deleterious for a unicellular organism. As a 
consequence, threshold levels for stress pathways activation and additional regulatory 
proteins have evolved in order to allow a more sophisticated  and d iversified  response, and  a 
less stringent cell death activation. In parallel, stress pathways have also d ifferentiated  with 
the progressive increase in cellular compartmentalization: new organelles and structures 
appear in eukaryotes or some organelles acquire new functions to allow the complex and 
highly specialized  communal life of a multi-cellular organism. Among them, the nucleolus is 
a nuclear compartment dedicated  to ribosome biogenesis and  therefore d irectly connected  to 
protein synthesis and  cell growth and proliferation. Not surprisingly, several stress sensors, 
such as MDM2, SIRT7, VHL and ARF are found as permanent or signal-induced residents of 
this structure, allowing the cell to couple energy availability and metabolism to cell 
proliferation during adverse conditions. In the nucleolus we find  also AATF, a transcription 
factor involved in rRNA processing, ribosomal biogenesis and  stress response, which in this 
thesis I show to be a necessary regulator of the AP-1 transcription factor c-Jun and of c-Jun-
mediated  cell death response. Moreover, I demonstrate that the pro-apoptotic role of AATF 
is associated  to its translocation from the nucleolus to the nucleoplasm, suggesting that 
AATF might play d istinct roles in d ifferent sub-cellular compartments, such as nucleolar-
associated  functions and c-Jun transcriptional regulation  in the nucleus. 
 
Similarly, also the other stress and apoptosis regulator  subject of this PhD study, the 
Cdk5/ p35 complex, changes localization upon d istinct stimuli and  thereby acquires distinct 
functions: in the cytoplasm Cdk5/ p35 is associated  to the intermediate filament nestin, and 
regulates cytoskeletal rearrangements such as those promoting cellular migration, while 
upon a stress signal, it translocates into the nucleoplasm where it can promote cell death. 
Here I show that the Cdk5/ p35 complex translocates to the nucleus also upon induction of 
d ifferentiation, identifying another common aspect of the d ifferentiation and apoptotic 
pathways, and  I show that this translocation is regulated  by the atypical PKCξ . Indeed, I 
describe how, on one hand , PKCξ  directly targets and  activates the calpain protease activiys 
and how, on the other hand, PKCξ  phoshorylates the calpain substrate p35, thereby enabling 
p35 cleavage and the consequent increase in Cdk5 activity. I demonstrate that both events, 
Introduction
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the activation of calpains and of the Cdk5/ p35 complex, are required  for muscle 
d ifferentiation and are dependent on PKCξ  activity .  
  
Introduction
  
11 
 
 
REVIEW OF THE LITERATURE 
 
1. Apoptosis 
Apoptosis is a form of regulated  cell death which eliminates unwanted , damaged or 
superfluous cells from the organism. It plays an indispensable role  during embryogenesis 
and  in adult tissues. Deregulation of apoptosis can contribute to pathogenic states (Ellis, 
Yuan, & Horvitz, 1991; Raff, 1992; Raff et al., 1993; Steller, 1995). For example, excessive 
apoptosis is known to take place in various d iseases, such as cerebral ischemia (reviewed by 
Broughton et al, 2009), AIDS (reviewed by Muthumani et al., 2003), and neurodegenerative 
d iseases (Rohn et al., 2010). Conversely, defective apoptosis, causing an excessive cell 
number accumulation, is a key characteristic of cancer development (reviewed by Hanahan 
& Weinberg, 2000). Apoptosis is an energy-dependent process characterized  by sequential 
steps of morphological changes (Wyllie, Kerr, & Currie, 1980). The dying cell undergoes 
nuclear and  cytoplasmic condensation, blebbing of the plasma membrane, and 
fragmentation into membrane-enclosed  apoptotic bodies. These bodies are subsequently 
identified and engulfed by phagocytic cells, such as neutrophils, monocytes, macrophages 
and dendritic cells. The endocytosis of apoptotic bodies avoids the induction of an 
inflammatory response, which instead  characterizes the necrosis type of cell death, an 
uncontrolled  process, in which the cell swells and  releases the cell contents into surrounding 
tissues (reviewed by Golstein & Kroemer, 2007).  
 
1.1. Apoptosis executers: the caspases 
Caspases are cysteine proteases which cleave their substrate proteins a t certain aspartate 
residues and are the main executers of the apoptotic pathway (Chowdhury, Tharakan, & 
Bhat, 2008). In most cell types, caspases are expressed  as catalytically inactive zymogens, 
consisting of a prodomain, a large p20 subunit, and  a small p17 subunit (Figure 1). The initial 
caspase activation process separates the large and small subunits, followed by removal of the 
N-terminal domain to form the catalytically active protease. Caspases are classically grouped 
into two classes: “initiator” caspases and  “executioner” caspases. The main role of the 
initiator caspases is to cleave and activate executioner caspases, while the executioner 
caspases are responsible for the proteolytic processing of other proteins (Riedl & Shi, 2004). 
The initiator caspases, including caspase-2, -8, -9, and  -10, have a longer N-terminal 
prodomain than the executioner caspases and contain one of two characteristic protein–
protein interaction motifs, the caspase recruitment domain (CARD) (Caspase-2 and -9) or the 
death effector domain (DED) (caspase-8 and -9) (Figure 1). These interaction motifs allow the 
recruitment of procaspases to specific death signaling complexes through the interaction 
with adaptor molecules which contain similar interactive motifs. Indeed the mechanism of 
activation of initiator caspases relies on specific adaptor proteins which promote the 
assembly of a caspase activating complex in response to death stimuli, followed by 
recruitment of procaspases. The result is an increase in local concentration of the initiator 
procaspases which allow zymogen dimerization and subsequent autocatalysis (Pop, 
Fitzgerald , Green, & Salvesen, 2007). 
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In mammals, four specific caspase activating comp lexes have been described:  1) the 
apoptosome, which enables the activation of caspase-9 via interaction with the adaptor 
APAF-1 (apoptotic protease-activating factor-1) in the presence of cytochrome c; 2) the death-
inducing signaling complex (DISC), which enables the activation of caspase-8 via interaction 
with the adaptor FADD; 3) the inflammasome, which regulates the activation of caspase-1 
and caspase-5 via interaction with the adaptor, ASC (apoptosis-associated speck-like protein 
containing a CARD) or the family of NLRs (nucleotide-binding and oligomerization domain 
(NOD)-like receptors); 4) the PIDDosome, which regulates the activation of caspase-2 via 
interaction with the adaptors RAIDD (RIP (receptor -interacting protein)-associated  ICH-
1/ CED-3 homologous protein with a death domain; also called  CRADD) and PIDD (p53-
induced protein with a death domain). 
The d ifferent caspase-activating complex are formed and activated  in response to d istinct 
pro-apoptotic and  pro-inflammatory signals, which suggest that they perform specific 
biological functions. For example, the apoptosome assembles upon loss of mitochondrial 
integrity and consequent release of cytochrome c, whereas the DISCs is formed upon binding 
of the Fas ligand (Fas-L) or of the tumor necrosis factor-α (TNFα) to their respective death 
receptors, as described  in more detail below. The executioner caspases, caspase-3, -6 and -7, 
need  to be cleaved by the initiator caspases in order to turn on their protease activity. When 
an initiator caspase cleaves the target caspases into fragments of 20 (p20) and 10 (p10) kDa, it 
allows the association and formation of a tetrameric enzyme complex derived  from the 
processing of two procaspase zymogens (Riedl & Shi, 2004). The active tetrameric protease 
consists of two homodimers formed by a large and a small subunit containing two active 
sites at opposite ends of the molecule (Figure 2). 
 
 
 
 
 
In addition, active executioner caspases trigger DNA fragmentation through the cleavage -
induced activation of the caspase-activated  DNase CAD (caspase-activated  DNAse) (Lüthi & 
Martin, 2007). Active caspases recognize and cleave proteins containing the peptide sequence 
X-Glu-X-Asp. Caspases-1, -4, -5 prefer the tetrapeptide WEHD. Caspases-2, -3, -7 prefer 
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DEXD, while caspase-6, -8, -9 prefer the sequence (L/ V)EXD. Active caspases associate to 
their substrates through interactions of the active site cleft with amino acids in the substrate 
cleavage site. Upon binding of the caspase to the substrate, the cleavage is accomplished  by 
hydrolysing peptide bonds on the carboxyl side of the aspartate residue  of the cleavage 
recognition motif X-Glu-X-Asp (Degterev et al., 2003). The sequential activation mechanism 
of caspases leads to the amplification of the original stress signal, which causes the cleavage 
of hundreds of structural and  regulatory proteins and the consequent death of the cell (Lüthi 
& Martin, 2007). 
While caspase activity is associated  with the onset of apoptosis , some caspases have also 
non-apoptotic functions: Caspase-1 is critical for inflammatory responses (Martinon, Burns, 
& Tschopp, 2002); Caspase-8 and its adaptor FADD are essential for apoptosis induced by 
death-receptors but also for blood vessel development, macrophage d ifferentiation and t he 
proliferation of certain cell types (Thome & Tschopp, 2001); Caspase-3 activity is necessary 
for muscle differentiation (Fernando, Kelly, Balazsi, Slack, & Megeney, 2002), for 
d ifferentiation of embryonic keratinocytes (Okuyama et al., 2004) and of some cancer cells 
such as K562 cells (Sztiller-Sikorska, Jakubowska, Wozniak, Stasiak, & Czyz, 2009).  
 
 
1.2 Two convergent pathways lead to caspase activation: the intrinsic and 
extrinsic pathway 
Vertebrates have two distinct apoptotic signaling pathways which ultimately converge in the 
activation of caspases: the intrinsic or mitochondrial pathway and the extrinsic or death 
receptor pathway. These pathways, and  their most central regulatory proteins, are d iscussed 
below. 
 
1.2.1 The intrinsic pathway  
The intrinsic apoptotic pathway utilizes a mitochondrial signaling route and is triggered  in 
response to many qualitatively d istinct stimuli, including DNA damage, cytokine 
deprivation, and  cytotoxic drugs. Activation of the intrinsic pathway leads to mitochondrial 
depolarization and release of cytochrom e c from the mitochondrial interm embrane space 
into the cytoplasm through proteolipid  pores formed  by the proapoptotic members of the  
Bcl-2 protein family, such as Bax and Bak (Chipuk, Bouchier-Hayes, & Green, 2006). In intact 
mitochondria, cytochrome c functions as an electron transporter in the respiratory chain 
located  in the mitochondrial inner membrane. Once released  into the cytosol, cytochrome c 
associates with APAF-1 and procaspase-9 and forms a complex called  the apoptosome. Here 
caspase-9 is activated  and promotes in turn, cleavage and activation of the executioner 
caspase -3, -6 and -7 (reviewed by Riedl & Salvesen, 2007). The intrinsic pathway is regulated 
by interactions between proteins related  to the Bcl-2 family members.  
 
1.2.1.1. The Bcl-2 family 
The members of the B-cell-lymphoma (Bcl) proteins, named after the human Bcl-2 oncogene 
(Tsujimoto et al., 1984), can be d ivided  based  on their pro- or anti-apoptotic role and  based 
on the number of Bcl-2 homology (BH) domains they possess, into three interacting groups 
(reviewed in Martinou et al., 2011) (Figure3): 
1) the pro-survival group, consisting of the Bcl-2 and its closest homologues, which share 
four BH domains;  
2) the pro-apoptotic group, the Bax group, which are very similar in sequence and structure 
to the pro-survival group; 
3) the apoptosis initiator group, the BH3-only proteins (Bad, Bid , Bim, Bik, Noxa and Puma) 
which possess only one BH domain, the so called BH3 domain  (Adams & Cory, 2007).  
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Most Bcl-2 family members contain a C-terminal hydrophobic trans-membrane (TM) region, 
which mediates their targeting and anchoring to the mitochondrial outer membrane and/ or 
to the ER (Figure 3).  
 
 
 
 
 
Figure 3. Structure of Bcl-2 family proteins. The Bcl-2 family is formed by three groups based  on 
their Bcl-2 Homology d omains (BH) and  function. Pro- and  antiapoptotic proteins have 4 BH domains, 
while BH3-only proteins, as their name ind icates, have only the BH3 domain  (ad apted  from Happo et 
al., 2012). 
 
 
The BH3-only proteins initiate apoptosis by binding to the hydrophobic surface of the pro -
survival family members and antagonizing their activities. The affinities of BH3-only 
proteins for pro-survival proteins d iffer markedly. BIM, tBID and PUMA bind with  high 
affinity to all pro-survival proteins, while Bad binds with high affinity only to Bcl-2, Bcl-X
L
 
and  Bcl-W, and Noxa only to MCL1 and A1 (reviewed in Martinou et al., 2011).  The activity 
of the BH3-only proteins is regulated  both transcriptionally an d  post-transcriptionally 
through post-translational modifications. For example, the transcription of noxa and  puma is 
induced by DNA damage and  is regulated  by the tumor suppressor p53, while bim 
transcription can be activated  by the forkhead transcription  factor FOXO3 upon cytokine 
withdrawal (Dijkers et al., 2000), by CHOP, a member of the C/ EBP transcription factor 
family, upon endoplasmic reticulum (ER) stress (Puthalakath et al., 2007), or by Myc (Egle et 
al., 2004). Bim is also regulated  by sequestration in a microtubule-associated  dynein motor 
complex in the cytoplasm of healthy cells and  its transcription seems to be regulated  by 
MAPK and PI3K pathways (Gross, McDonnell, & Korsmeyer, 1999). Bad is phosphorylated 
by Akt, and  thereby kept sequestered  in the cytoplasm by 14-3-3 (Zha, Harada, Yang, Jockel, 
& Korsmeyer, 1996). Upon stress, Bad is dephosphorylated  and subsequently released from 
14-3-3 proteins, enabling Bad to relocalize to mitochondria. In contrast, Bid  is activated  when 
cleaved by caspase-8 or caspase-10. The truncated  Bid , tBid , can be myristoylated  which is 
required  for targeting tBid  to the mitochondria (Puthalakath & Strasser, 2002). Importantly, 
the pro-apoptotic Bcl2 members Bax and Bak are necessary for mitochondrial apoptosis as 
double knock-out mice models show an impaired  mitochondrial outer membrane 
permeabilization and resistance  to a wide range of apoptotic stimuli (Wei et al., 2001). While 
Bax is predominantly a cytosolic monomer in healthy cells, during apoptosis it undergoes 
conformational changes, translocates to the outer mitochondrial membrane and 
oligomerizes. On the contrary, Bak is already localized  at the mitochondrial membrane 
under normal growth conditions, but upon apoptotic stimuli it changes conformation and 
forms larger aggregates which permeabilize mitochondria and allow the passage of 
cytochrome c. Therefore, Bax and Bak together permeabilize the outer mitochondrial 
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membrane, allowing efflux of apoptogenic proteins and initiation of the caspase cascade. The 
precise mechanism by which Bak and Bax mediate mitochondrial apoptosis is still unclear, 
and  will not be further d iscussed  in this thesis (Green, 2006; Willis & Adams, 2005) 
 
Caspase activation may further be regulated via binding to specific inhibitors, the IAPs 
(inhibitors of apoptosis). IAPs are a family of proteins, originally identified  in insect cells 
infected  by the baculovirus (Roy et al., 1995, Cheng et al., 1996 and  Salvesen and Duckett, 
2002). In human, six IAP members have been identified : NAIP (neuronal apoptosis 
inhibitory protein), c-IAP1, c-IAP2, XIAP (X-linked mammalian inhibitor of apoptosis 
protein), survivin and BRUCE (Deveraux and  Reed, 1999). All IAP members contain one to 
three N-terminal baculovirus IAP repeat (BIR), a novel domain of 70–80 amino acids forming 
a zinc finger like structure which can chelate zinc ions. The BIR domains can bind  to the 
surface of caspases and thereby inhibit caspases activities. The executioner caspases, caspase-
3, -7 and -9 can all be inhibited  by IAPs (Salvesen & Duckett, 2002). However, not all BIR-
containing proteins are inhibitors of caspases. For example, survivin, which has only one BIR 
domain, seems to function as a regulator of mitosis rather than apoptosis. In turn, the activity 
of human IAPs can be inhibited  by Smac/ Diablo proteins released  by the mitochondria 
(Green & Kroemer, 2004; Jost et al., 2009) 
 
 
1.2.2. The extrinsic pathway 
The extrinsic apoptotic pathway is initiated  by the binding of ligands to specific death 
receptors (DRs) on the plasma membrane. The activation of death receptors  promotes the 
formation of cytoplasmic caspase-activating protein complexes, which will ultimately induce 
apoptosis (Aggarwal, 2003) (Figure 4). The extrinsic pathway is responsible for the 
elimination of unwanted  cells during development , immuno-surveillance for tumor cells 
removal and  the regulation of the immune system when stimulated  upon death receptor 
ligation. To date, six DRs have been identified : TNFR1 (p55), CD95 (Fas/ Apo), DR3 
(TRAMP), DR4 (TRAIL-R1), DR5 (TRAIL-R2) and DR6. DRs are activated  by binding to their 
ligands which belong to the TNF superfamily of cytokines. Most death receptor ligands are 
expressed  as type II transmembrane proteins predominantly on the cell surface of immune 
cells, while their respective receptors are expressed  in a wide range of tissues as type I 
transmembrane proteins as preassembled homotrimers (reviewed by Nagata 1997). Death 
receptors can be d ivided  into two types according to the adaptor protein t o which they 
associate upon ligand binding. The adaptor proteins contain binding domains to the death 
receptors and docking sites for other downstream signaling molecules. Fas, TRAIL-R1 and 
TRAIL-R2 recruit the adaptor protein FADD and primarily mediate proapoptotic signals, 
whereas TNFR1 and TRAMP bind  the adaptor protein TRADD and mediate mainly 
proinflammatory and imm une-stimulatory activity (Hsu, Xiong, & Goeddel, 1995).  
 
As an example of the first DR group, Fas is activated  by binding to its ligand, FasL, which 
initiates the rapid clustering of the receptors (Figure 4). Fas recruits FADD and caspase-8 to 
form the death-inducing signaling complex (DISC), where caspase-8 and caspase-10 are 
activated by induced proximity (Medema et al., 1997; Muzio, Stockwell, Stennicke, Salvesen, 
& Dixit, 1998). Recruitment of c-FLIP to the Fas-DISC regulates caspase-8 activation and 
promotes anti-apoptotic Fas signaling (Thome & Tschopp, 2001). TNFR1 signaling represents 
the second DR group and is mediated  by the formation of two d ifferent complexes which can 
either activate the NF-κB pathway from the cell surface (Complex I) or initiate apoptosis 
from the internalized  receptors (Complex II) (Micheau & Tschopp, 2003) (Figure 4). Complex 
I forms upon binding of the ligand TNFα to the receptor TNFR1 which induces the 
recruitment of the adaptor protein TRADD and consequent binding of TRAF2, cIAP1, cIAP2 
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and RIP1. Here, RIP1 ubiquitination allows for activation of IKK complex which regulates 
the phosphorylation-mediated  degradation of IkBα , the NF-κB inhibitor protein. The 
stabilized  NF-κB translocates to the nucleus and induces the expression of antiapoptotic 
genes such as cIAP-1, c-IAP-2, cFLIP, TRAF1 and  TRAF2 (Wilson, Dixit, & Ashkenazi, 2009). 
Alternatively, TNFR1 can be endocytosed  upon TNFα binding . In this case, RIP1 is 
deubiquitinated  and another complex, the pro-apoptotic Complex II (also called  DISC), can 
form. This complex includes TRADD, FADD and procaspase-8. The complex II pathway 
resembles the pro-apoptotic cascades induced by Fas-L and is regulated by c-FLIP, c-IAPs 
and the deubiquitinating enzyme CYLD (Micheau & Tschopp, 2003; L. Wang, Du, & Wang, 
2008; Wilson et al., 2009). Hence, it seems that the seem ingly contradictory functions of the 
death receptors, such as survival and  apoptosis, are mediated  by the d ifferent receptor 
complex which can form either at the plasma membrane or when endocytosed  into the 
intracellular compartments (reviewed in Schuetze et al. 2008). 
 
 
 
 
 
 
Figure 4. Death Receptor Complexes. (A) Formation of the death inducing signaling complex (DISC) 
via stimulation of Fas by its respective ligand  FasL. Fas ligation triggers d irect recruitment of the 
adap tor FADD which binds procaspase-8 (or procaspase-10) via its DED domain. Here initiator 
caspases are activated  by induced  proximity. c-Flip  blocks this process through d irect bind ing and  
inhibition of procaspase-8. (B) Tnfα ligation triggers receptor endocytosis, internalization and  
assembly of a caspase activation complex. Upon end ocytosis the ad aptor TRADD associates to TnfR1 
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and , than binds FADD through interaction between their DD d omains. FADD in turn recruits 
procaspase-8 and / or procaspase-10 and  initiate apoptosis. (C) Binding of Tnfα to TnfR1 promotes the 
assembly of Complex I at the plasma membrane which consists of the ad aptor protein TRADD, the 
kinase RIP-1 and  the signal transducer TRAF2. IKK is recruited  to complex I by RIP-1 and  TRAF2 and  
is here activated . IKK activation leads to I-κB degradation and  consequent NF- κB stabilization and  
activation. 
 
 
1.2.2.1. Death ligands  
Classically the activation of the extrinsic pathway relies on the expression level, ava ilability 
and binding of the matching ligand to the correspondent receptor. The death ligands belong 
to the TNF ligand family of type II transmembrane proteins characterized  by a conserved C -
terminal extracellular TNF homology domain (THD) required  for ligand trimerization. The 
ligands are synthetized as membrane-associated  proteins, but they can be cleaved  by 
proteolytic enzymes such as metalloproteases (Ethell, Kinloch, & Green, 2002; Mitsiades, Yu, 
Poulaki, Tsokos, & Stamenkovic, 2001). Some TNF ligands require solubilisation in order to 
function, whereas cleavage inhibits the physiological functions of others (Suda et al., 1997). 
Proteolytic shedding of TNFα  (R. A. Black et al., 1997) and Fas-L produces soluble forms that 
might have a reduced  ligand activity (Tanka et al., 1995; O´Reilly at al., 2009). Interestingly, 
death ligands can also activate signaling pathways that promote proliferation and survival. 
TNFα, for example, functions as a proinflammatory cytokine that induces proliferation and 
d ifferentiation, but also mediates caspase activation and apoptosis in certain cell types 
(Aggarwal, 2003). The expression of Fas-L is tightly regulated  at the level of transcription and 
can be induced by several transcription factors such as NFAT, NF-κB, c-Myc, IL-2, Sp-1, AP-1 
and Egr (Kavurma & Khachigian, 2003). Upon stress Fas-L is induced by JNK members 
(Faris, Latinis, Kempiak, Koretzky, & Nel, 1998). Binding of Fas-L, TRAIL and TNFα  to the 
correspondent receptor, also activates the JNK pathway (Y. Lin et al., 2000; Z. G. Liu, Hsu, 
Goeddel, & Karin, 1996; Wajant, Pfizenmaier, & Scheurich, 2003). Activation of the JNK 
pathway has been found to be necessary to Fas-mediated  apoptosis but not for TNF-R1-
induced cell death  (reviewed in Liu and Lin, 2007). The best known targets of JNK are the 
AP-1 members ATF-2 and c-Jun that participate in the induction of TNFα and  Fas-L following 
cellular stress or T cell activation. 
 
1.3. The AP-1 transcription factors family 
AP-1 (Activator Protein 1) was identified  as a transcription factor that regulates both basal 
gene expression (W. Lee, Haslinger, Karin, & Tjian, 1987), and  TPA (phorbol 12O-
tetradecanoate-13-acetate)-inducible gene expression (Angel et al., 1987). However, AP-1 
activity was soon thereafter shown to be potently induced also by several other types of 
stimuli, including serum stimulation  (Lamph, Wamsley, Sassone-Corsi, & Verma, 1988), 
growth factors (Ryder & Nathans, 1988) (Quantin & Breathnach, 1988), oncoproteins (Angel 
& Karin, 1991; Mechta, Lallemand, Pfarr, & Yaniv, 1997), TNFα (Brenner, O’Hara, Angel, 
Chojkier, & Karin, 1989), and  IL-1 (Muegge et al., 1989). The findings that growth factors and 
oncogenes induce AP-1 activity immediately suggested  the importance of AP-1 in growth 
control and  transformation  (Jochum, Passegué, & Wagner, 2001). Also, the capacity of AP-1 
to induce proinflammatory cytokines and the identification of the AP-1 target genes 
collagenase (Angel et al., 1987) and IL-2 (Muegge et al., 1989), suggested  the involvement of 
AP-1 in inflammation and innate response. In addition to physiological stimuli, AP-1 activity 
is induced by a variety of environmental stresses, most notably short wavelength UV 
radiation (Devary, Gottlieb, Lau, & Karin, 1991; Herrlich, Ponta, & Rahmsdorf, 1992). 
 
The mammalian AP-1 proteins form homodimers or heterodimers composed of basic region -
leucine zipper (bZIP) proteins that belong to the Jun (c-Jun, JunB, and JunD), Fos (c-Fos, 
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FosB, Fra-1 and Fra-2) and the closely related  activating factor (ATF2, ATF3 and B-ATF) 
subfamilies (Chinenov & Kerppola, 2001; van Dam & Castellazzi, 2001; Vinson et al., 2002). 
The less studied  group of AP-1 proteins is the Maf subfamily that recent works have shown 
to play key roles in expression regulation, cellular d ifferentiation and oncogenesis (reviewed 
in Kannan et al., 2012). Jun proteins can form stable d imers that bind  the AP-1 recognition 
elements (5’TGAG/ CTCA-3’), known as TRE (TPA- response elements) (Angel et al., 1987). 
Fos proteins do not form stable homodimers but bind  DNA through heterodimerization with 
the Jun proteins (Halazonetis, Georgopoulos, Greenberg, & Leder, 1988; Kouzarides & Ziff, 
1988). ATF proteins can form both homodimers and heterodimers with the Jun proteins and 
preferentially bind  to cAMP responsive elements (CRE, 5’- TGACGTCA-3’) when d imerized 
with the Jun proteins. Thus the d ifferential expression and d imerization partner of AP-1 
proteins in response to extracellular stimuli is one major mechanism  of regulation (Schütte 
et al., 1989). Indeed , the d ifferent components forming the AP-1 complex determines the 
binding specificity and consequently the spectrum of AP-1 targeted  genes. Additionally, 
post-translational modifications, in particular phosphorylation, further modulate AP -1 
activities and  provide another link for extracellular stimuli to regulate AP-1 transcriptional 
activity (M Karin, 1995). Practically, all branches of the MAPK cascades have been found  to 
be involved in the regulation of AP-1. Serum and growth factors induce AP-1 activities by 
activating the ERK branch of MAPKs, whereas pro-inflammatory cytokines and genotoxic 
stress induce AP-1 mostly by the JNK and p38 MAPKcascades (Chang & Karin, 2001; M 
Karin, 1995; Kyriakis & Avruch, 2001). Once activated , MAPKs translocate into the nucleus 
where they can d irectly phosphorylate and activate the AP-1 transcription factors. The 
primary effect of the MAPK-mediated  phosphorylation is the potentiation of AP-1 
transactivation without having a considerable effect on their DNA-binding ability (Karin, 
1995). In this thesis, I focus on the c-Jun AP-1 family member and specifically on the role of c-
Jun in cell death regulation. 
 
1.3.1. c-Jun 
c-Jun is, together with the Fos proteins, the major member of the AP-1 family. c-jun was 
identified  in 1987 by its homology to v-jun, the oncogene found  in the avian sarcoma virus 
ASV17 (Maki, Bos, Davis, Starbuck, & Vogt, 1987). A few years later, two other c-jun-related 
genes, junB and  junD, were identified  based  on the sequence similarity to c-Jun (Hirai, 
Ryseck, Mechta, Bravo, & Yaniv, 1989; Ryder, Lanahan, Perez-Albuerne, & Nathans, 1989). 
Jun proteins can function as homodimers or as heterodimers bound to Fos-related  proteins, 
CREB or ATF-2 (Hai & Curran, 1991; van Dam et al., 1993). The d imerization is mediated  by 
a C-terminal coiled -coil leucine zipper that is necessary for binding to the palindromic 
sequence of the AP-1 consensus site, also known as the TPA-responsive element (TRE) 
(reviewed in Vogt and Bos, 1990, Angel and  Karin, 1991). Therefore, d ifferent Jun 
homodimers and heterodimers form a large number of d imer combinations with d istinct 
transcriptional properties and d ifferent biological outcomes. For example, the importance of 
the d imerization partner of c-Jun for its transformation capacity was shown by the 
demonstration that c-Jun-ATF2 heterodimers mediated  the induction of autocrine growth 
while c-Jun-Fos heterodimers promoted  anchorage-independent growth  (Van Dam et al., 
1998). 
 
c-Jun is composed of a N-terminal region containing a JNK binding site and  the 
transactivation domain (aa 1-191), a positively charged domain (aa 257-276), the leucine 
zipper (aa280-308) and a C-terminal region (Figure 5). Changes in the activation of c-Jun 
transcriptional activity depend on the chemical modification at three d ifferent sites:  
1) the phosphorylation of the N -terminal region serine 63 and 73 (Ser63&73) and threonine 
91 and 93 (Thr91&93) (Morton, Davis, McLaren, & Cohen, 2003; Smeal, Binetruy, Mercola, 
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Birrer, & Karin, 1991); 2) the dephosphorylation of Thr239 (Morton et al., 2003); 3) the 
acetylation of lysine residues in the basic, near C-terminal region aa 257-276 (Wang et al., 
2006).  
These modifications are under a d irect or indirect control of the JNKs, the ERKs and the p38 
MAPK components of the MAPK family.  
 
 
 
 
 
Figure 5. Schematic structure of human c-Jun. The N-terminal domain contains the JNK bind ing 
domain (δ ) and  the phospho-sites targeted  by JNK (Ser63, 73 and  Thr91, 93). Amino acids 1- 190 form 
the transcrip tional transactivation domain . GSK-3β mediated  phosphorylation of Thr239, together 
with Ser243 attracts the FBW7 ubiqu itin ligase and  targets phosphorylated  c-Jun to ubiquitination and  
degradation. The DNA bind ing domain is a basic positively charged  domain (aa 257-276) followed  by 
the leucine zipper domain which mediates c-Jun d imerization. P300-med iated  acetylation of the DNA 
bind ing domain resu lts in JNK-independent activation of c-Jun. 
 
 
Phosphorylation of c-Jun on Thr239 and Ser243 function as a docking site for the F-box&WD 
domain repeated  7 (FBW7) ubiquitin ligase which mediates the subsequent degradation of c-
Jun (W. Wei, Jin, Schlisio, Harper, & Kaelin, 2005). Ser243 phosphorylation primes c-Jun for 
glycogen synthase kinase-3 (GSK-3)-mediated  phosphorylation of Thr239 site (Morton et al., 
2003). The phosphorylation of Thr239 is blocked by the substitution of Ser243 with  
phenylalanine in the transforming, viral form of the protein and causes the stabilization of 
viral Jun protein (v-Jun) (Boyle et al., 1991; W. Wei et al., 2005). The phosphorylation of both 
sites, Thr239 and Ser243, is required  for binding of FBW7, so loss of both negative charges in 
v-Jun, or just one at Thr239 upon GSK3 inhibition, seems to be sufficient to stabilize c-Jun. 
Interestingly, abrogation of JNK-targeted  phospho-sites, i.e. Ser63/ 73 and Thr91/ 93, also 
block FBW7-mediated  degradation of c-Jun independently of the Thr239 and Ser243 pair, 
suggesting that the N-terminal phospho-sites constitute an alternative degradation pathway 
for the preferential removal of the phosphorylated  and activated  c-Jun (Nateri, Riera-Sans, 
Da Costa, & Behrens, 2004). Interestingly, the v-Jun form also carries a large deletion of aa32-
58 in the JNK docking domain which precludes JNK binding and N -terminal 
phosphorylation (May et al., 1998). This deletion could  explain why v-Jun only depends on 
the mutation of the Thr239/ Ser243 pair in order to escape FBW7-mediated  degradation. 
Finally, post-translational modification in the C-terminal basic region can strongly affect c-
Jun transcriptional efficiency. Upon certain stimuli, such as growth factor treatment , c-Jun 
activation depends on p300-mediated  acetylation of lysine residues in the  basic DNA 
binding domain (Vries et al., 2001; Y.-N. Wang, Chen, & Chang, 2006). For example, Wang 
and coworkers showed that substitution of the three lysines Lys268, Lys271 and Lys273 with 
arginine residues completely inhibits the epidermal growth factor-mediated  activation of c-
Jun, indicating that upon d istinct stimuli c-Jun activity depends from the acetylation of its 
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basic C-terminal domain. By far the most well-known and potent activator of c-Jun 
transcriptional activity is the phosphorylation of the N -terminal domain operated  by the JNK 
kinases, d iscussed here below . 
 
1.3.1.1. The JNK pathway 
Three d ifferent genes (JNK1, 2, 3) are alternatively spliced  to form at least ten JNK isoforms 
(reviewed in Barr & Bogoyevitch, 2001; Dhanasekaran & Reddy, 2008). JNK1 and JNK2 are 
ubiquitously expressed , while the expression of JNK3 is mainly restricted to the brain and to 
a lesser extent to the heart and  testis. The activation of JNK is mediated  by the MAP cascade 
of sequential phosphorylations in which MAP3K phosphorylates and activates a MAP2K 
and which in turn phosphorylates MAPK (Figure 6). Two MAP2Ks (the 
JNKK1/ MKK4/ SEK1 and JNKK2/ MKK7) phosphorylate the MAPK subfamily JNK on the 
T-loop at Thr183 and Tyr185 and these phosphorylation events are required  for JNK full 
activation (Dérijard  et al., 1994; A. Lin et al., 1995; Sánchez et al., n.d .). JNK activation is also 
tightly regulated  by many scaffold ing proteins such as JIP, b-arrestin and JSAP, (M. Ito et al., 
1999; Whitmarsh, Cavanagh, Tournier, Yasuda, & Davis, 1998) and MAP phosphatases (M 
Karin, 1995). Lastly, recent studies have shown that JNK activity can be negatively or 
positively regulated  by NF-κB for inhibition or promotion of cell death induced by TNFα 
and  UV, respectively (J. Liu et al., 2006; G. Tang et al., 2001). In addition, JNK phosphorylates 
and regulates the activities of other transcription factors such as ATF-2, Elk-1, p53 and c-Myc 
(Buschmann et al., 2001; Fuchs et al., 1997; Noguchi et al., 1999) and is involved in the 
regulation of non-transcription factors such as the members of the Bcl-2 family, Bim and Bad 
(Chang & Karin, 2001; Davis, 2000). Upon binding to c-Jun, JNK phosphorylates two 
serine/ threonine clusters, Ser 63/ 73 and Thr 91/ 93, and  thereby potentiates c-Jun 
transcriptional capacity without having a significant effect on its DNA binding capacity (M 
Karin, 1995; Musti, Treier, & Bohmann, 1997) (Figure 6). JNK1 is the major isoform 
responsible for c-Jun terminal phosphorylation that is also the major isoform activated  by 
UV-irradiation (Devary et al., 1991; J. Liu, Minemoto, & Lin, 2004; Sabapathy & Wagner, 
2004). On the contrary, JNK2 seems to function mainly to target c-Jun for ubiquitination and 
degradation under normal growth conditions (Fuchs, Dolan, Davis, & Ronai, 1996). How 
JNK1 and JNK2 are differentially regulated is not yet understood. JNK phosphorylation 
controls c-Jun activity also by modulating the interaction between c-Jun and transcriptional 
co-repressors such as histone deacetylase 3 (HDAC3) or by regulating the nuclear 
localization of AP-1 regulators, such as the RNA helicase RHII/ Gu  (Weiss et al., 2003; 
Westermarck et al., 2002). In addition, JNK1 phosphorylation has been suggested  to increase 
the half-life of c-Jun, enabling the robust and  prolonged expression after exposure of cells to 
stress such as UV radiation (Musti et al., 1997).  
 
1.3.2. c-Jun role in apoptosis 
The consequence of AP-1 activation is cell type specific (Potapova et al., 2001; Scherer et al., 
2000; Wisdom et al., 1999). The biological outcome of the activation of the AP-1 complexes is 
highly dependent on the composition, post-translational modifications and presence of 
interacting factors within the complex. The clearest demonstration of the involvement of AP-
1 in promoting apoptosis came from studies on the nervous system. Inhibition of c-Jun 
activity with a dominant negative mutant lacking the c-Jun N-terminal activation domain or 
by neutralizing antibodies, reduced apoptosis in  neuronal cells induced by nerve growth 
factor (NGF) deprivation or chronic depolarization (Ham et al., 1995; Le-Niculescu et al., 
1999; Xia, Dickens, Raingeaud, Davis, & Greenberg, 1995). Conversely, overexpression of c-
Jun induces apoptosis in several cell lines (Bossy-Wetzel, Bakiri, & Yaniv, 1997; Ham et al., 
1995). Also, expression of the phosphorylation -deficient c-Jun S63/ 73A mutant blocked 
apoptosis induced by NGF withdrawal in cultured  neuronal cells as efficiently as treatment 
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with several JNK inhibitors, indicating that phosphorylation of c-Jun is necessary to promote 
c-Jun-mediated  apoptosis (Le-Niculescu et al., 1999; Watson et al., 1998). The dominant 
negative c-Jun mutant also reduced apoptosis in human monoblastic leukemia cells after 
exposure to various DNA damaging agents (Verheij et al., 1996). Accordingly, both c-Jun-
deficient fibroblasts and JNK1/ JNK2-deficient fibroblasts are resistant to apoptosis induced 
by UVC radiation (Shaulian et al., 2000; Tournier et al., 2000). However, only persistent, but 
not transient JNK activation promotes apoptosis (Hibi, Lin, Smeal, Minden, & Karin, 1993) 
(Chen, Wang, Templeton, Davis, & Tan, 1996). Indeed, persistent JNK activation in cells 
exposed to moderate to high levels of UVC (12-40 J/ m2) can result in a c-Jun induction 
lasting 24 h or longer (Shaulian et al., 2000). Moreover, it seems that c-Jun induction is 
necessary for cell cycle re-entry of UV-irradiated  fibroblasts; indeed, while wild  type 
fibroblasts undergo a transient cell cycle arrest after UV exposure, c-jun deficient cells 
undergo prolonged growth arrest and  fail to resume proliferation  (Shaulian et al., 2000). 
Conversely, cells that constitutively express c-Jun fail to arrest and  continue to cycle after UV 
exposure.  
 
It is likely that the pro-apoptotic effects of AP-1 are due to transcriptional activation of AP-1 
target genes which promote apoptosis (Figure 6). For example, several studies have shown 
that AP-1 induces expression of the pro-apoptotic genes Fas-ligand (Fas-L), Tnfα and Bim 
(Kasibhatla et al., 1998; Kolbus et al., 2000; Le-Niculescu et al., 1999). Moreover, c-Jun KO 
fibroblasts, which are resistant to apoptosis induced by UV radiation and alkylating agents, 
show an impaired  expression of Fas-L (Kolbus et al., 2000). However, there is no clear 
explanation why some activators of AP-1 lead  to Fas-L induction and others not. It has been 
suggested  that AP-1 plays a homeostatic function , which allows adjustment of the gene 
expression profile to changes in the environmental conditions, and  enable the cell to adapt to 
the new environment. Moreover, upon excessive environmental stress, other stress pathways 
could  be induced which may interact with the AP-1 complexes and promote cell death.  
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Figure 6. JNK signaling pathway in apoptosis. JNK is activated  by a wide range of extracellu lar 
stimuli through the MAPK module consisting of a sequence of phosphorylation events. JNK is 
selectively phosphorylated  by MKK4 and  MKK7. Upon activation JNK targets Bcl-2 proteins, such as 
Bax, Bim and  Bid , and  translocates into the nucleus where it phosphorylates and  contributes to 
stabilize p53 and  activates the AP-1 factors c-Jun and  ATF-2. Activated  c-Jun d imers induce the 
proapoptotic genes Fas-L and  Tnfα which are thought to be important med iators of c-Jun-mediated  
apoptosis. It is likely, however, that add itional unidentified  gene targets also contribute to apoptosis.  
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1.4. The UV response 
UV exposure results in the simultaneous activation and  inhibition of multiple signaling 
pathways which play critical roles in cell-type specific control of survival or death. The main 
source of UV radiation is sunlight. The shortest wavelength, UV-C (240-290 nm) is absorbed 
by atmospheric ozone, while 90% of the UV radiation which reaches the surface of the Earth 
is constituted  by UV-A (315-280 nm) and approximately a 10% by UV-B (280-315 nm). 
However, the proportion of shorter wavelengths is increasing due to ozone depletion. Cells 
contain photosensitive molecules (chromophores) which, upon receiving photons from UV 
radiation, subsequently lift electrons to a higher and more reactive energetic state. The main 
cellular chromophores for UV radiation are DNA and reactive oxygen -generating molecules 
(Ravanat, Douki, & Cadet, 2001). Due to the aromatic ring structures of its bases, DNA 
absorbs short-wavelength very efficiently, subsequently forming pyrimidine dimers and (6-
4)-photoproducts which cross-link adjacent DNA bases (Cadet, Sage, & Douki, 2005). These 
UV-induced d istortions in the DNA helix block RNA polymerase elongation, thus inhibiting 
gene expression. The helix-d istorting DNA adducts are repaired  by nucleotide excision 
repair (NER) system whose effectors have been named according to seven complementation 
groups of Xeroderma pigmentosum (XP, XPA to XPG) (reviewed in Hoeijmakers, 2001). UV 
radiation causes also the accumulation of reactive oxygen intermediates (ROI), short lived 
intermediates including singlet oxygen, superoxide anion radical, hydroxyl radical. ROIs 
accumulation results in lipid  peroxidation and also oxid ize DNA sugar derivatives, modify 
bases, and  cause single- and  double-strand breaks (H. S. Black, 2004; Epe, 1996).  
 
The primary DNA damage sensors are the phosphoinositide-3-kinase (PI-3-kinase)-related 
proteins ataxia telangiectasia-mutated  (ATM) and ataxia telangiectasia-related  (ATR), which 
have overlapping functions. ATM is essential for IR-induced and ATR for UV-induced 
phosphorylation of several downstream G1/ S checkpoint proteins, such as the Chk1 and 
Chk2 kinases (Kastan & Bartek, 2004; Shiloh, 2003). These, in turn, phosphorylate the 
Cdc25A phosphatase, leading to Cdc25A degradation and cell cycle arrest. ATM/ ATR 
kinases also phosphorylate the tumor suppressor p53, thereby stabilizing it (reviewed in 
Appella & Anderson, 2001; Kruse & Wei, 2009). UV-induced protein oxidation can initiate 
cell signaling by inactivating protein tyrosine phosphatases (PTPs) (Tonks, 2006). PTPs 
contain a highly reactive cysteine in their catalytic pocket. Oxidation of this cysteine 
inactivates PTPs and results in elevated  phospho-tyrosine-dependent signal transduction. 
For example, upon PTP oxidation, firing of the EGF receptor is increased  (Knebel, 
Rahmsdorf, Ullrich, & Herrlich, 1996; Sachsenmaier et al., 1994). MAPK phosphatases 
(MKPs), a specialized  class of PTPs can also be similarly oxidated , resulting in a prolonged 
activation of MAPKs, especially JNK and p38 (Hamdi et al., 2005). As a third  example, 
inactivation of PTEN, a PIP3 phosphatase, increases signaling by decreasing PIP3 turnover 
(S.-R. Lee et al., 2002). As a result, UV radiation provokes the clustering and internalization 
of several cell surface growth factor and cytokine receptors in a ligand -independent manner, 
resulting in the activation of downstream signaling cascades, a reason why the UV-response 
has been regarded as a “pseudo growth response”  (Herrlich, Blattner, Knebel, Bender, & 
Rahmsdorf, 1997; Herrlich et al., 1992). A well-know MAPK cascade activated  by UV 
exposure is the JNK and p38 kinase which , importantly, are only transiently induced and 
lead  to AP-1 activation (Hildesheim & Fornace, 2004; Rosette & Karin, 1996). 
 
The induction of cell cycle arrest upon DNA damage gives the cells time for DNA repair 
before replication resumes. The key regulatory protein involved in the induction of growth 
arrest by UV is p53 (Toledo & Wahl, 2006). Exposure to UV results in rapid  p53 
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accumulation, caused  by the stabilization of this otherwise short -lived  protein. p53 
accumulation causes the induction of several p53 target genes including p21, Mdm2, Gadd45 
and  Bax. p21 is an inhibitor of cyclin-dependent kinases (Cdks) and is responsible for the 
induction of cell cycle arrest upon UV exposure. Importantly, DNA damage induces the 
rapid  nucleolar translocation of HDM2 which targets p53 to degradation,  and  is essential for 
a proper DNA damage response through stabilization of p53 levels (Kurki et al., 2004; Rubbi 
& Milner, 2003).  
 
2. Anti-Apoptosis-Transcription-Factor, AATF 
Anti-Apoptosis-Transcrip tion Factor (AATF /  Che-1) is a RNA polymerase II binding 
protein involved in the transcriptional regulation of E2F target-genes and in cell 
proliferation. It does so by d irectly binding to the retinoblastoma protein (Rb) and inhibit ing 
its ability to suppress expression of E2F genes by removing HDACI from E2F-target 
promoters (Tiziana Bruno et al., 2002; Fanciulli et al., 2000). However, AATF also has anti-
proliferative activity as it can d irectly bind  to the  p21 promoter and  induce p21 expression 
(Tiziana Bruno et al., 2006). Accordingly, in human colon carcinoma cell lines, 
overexpression of AATF induces cell cycle arrest by upregulating p21 expression in a p53-
independent manner (Tiziana Bruno et al., 2006; Di Padova et al., 2003). Consistently AATF 
is downregulated  in several tumors, including kidney, prostate and  colon carcinoma (Di 
Padova et al., 2003) .On the p21 gene promoter, AATF displaces HDAC1 from the Sp1 
binding sites, suggesting that AATF might act as a general HDAC1 competitor and  as an 
activator of  transcription (Di Padova et al., 2003).  
AATF is a highly conserved protein from yeast to mammals and its expression during 
embryogenesis is necessary for the preimplantation of the embryo (Thomas, Voss, Petrou, & 
Gruss, 2000). Indeed, the targeted  d isruption of AATF is lethal as it prevents the 
estabilishment of an embryonic gene expression profile and  leads to the decompactation of 
the embryo. AATF-deficient mouse embryo is characterized  by a 50% reduction in  the total 
cell number and  cells contain a reduced  number of ribosomes. This paucity of ribosomes 
and the localization of AATF to the nucleoli, the site of ribosome synthesis, suggest that 
AATF might be involved in the biogenesis of ribosomes (Thomas et al., 2000).  
Furthermore, AATF was identified  as an interacting factor of DAP like kinase (Dlk), a 
member of the DAP (death -associated  protein) kinase family of pro-apoptotic serine-
threonine kinases and was named based  on its capacity to antagonize Dlk-induced apoptosis 
(Page, Lödige, Kögel, & Scheid tmann, 1999).  
 
2.1. Structure and physiological functions 
AATF was originally identified  in a two-hybrid  screen as a binding protein of RNA 
polymerase II (Fanciulli et al., 2000). Soon after, Monaco and coworkers (2003) cloned the 
murine AATF, which encodes a protein of 526 amino acids but lacks the correspond ing 
human exon coding for amino acids 146-177. In this work, the authors also showed that the 
mouse coding sequence of AATF consists of 1581 bp, subdivided  into 13 exons spanning 35 
kb on chromosome 17q11.2-q12, and  that the AATF promoter region  does not contain any 
TATA or CAAT boxes (Monaco et al., 2003). Interestingly, AATF expression was shown to be 
regulated  by a negative feedback mechanism, as AATF associated  to its own promoter and , 
thereby, repressed  its own transcription.  
 
AATF is ubiquitously expressed , with the highest expression in the heart, brain, lung and 
testis (Monaco, Passananti, & Fanciulli, 2003). Three d ifferent splicing isoforms of AATF 
have been detected . Isoform 1 corresponds to the full length form of 1581 bp, whereas 
isoform 2 lacks exons III-IV (amino acids 85-199) and isoform 3 consists of a d ifferently 
spliced  C-terminal tail which lacks exons XI-XIII (amino acids 459-526) and encodes a 
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different exon XI translating amino acids 433-458 
(LLRELIERKTSSLDPNDQVAMGRQWL → VRLFLSFLCYNKPGVCILEPLIVSSG) as 
summarized  in Figure 7. 
 
 
 
 
 
 
Figure 7. Murine AATF isoforms. Full length AATF (AATF1) is formed by 13 exons corresponding 
to a cod ing sequence of 1581 bp. Alternative sp licing generates an AATF isoform missing exons III-IV 
(AATF2) or a d ifferently C-terminal sliced  variant (AATF3) lacking exons XI-XIII and  encoding a 
d ifferent exon XI (AATF3). 
 
 
 
Inspection of the amino acid  sequence reveals the presence of a canonical leucine zipper 
motif, two highly acid ic amino-terminal regions which are characteristic of several chromatin 
remodelling factors, such as VP16 and BRCA-1, various phosphorylation sites and  three 
nuclear receptor binding LxxLL consensus sequences (Heery, Kalkhoven, Hoare, & Parker, 
1997) (Figure 8). Two putative nuclear localization signals are present and  indeed AATF is 
mainly localized  in the nucleus and nucleoli (Andersen et al., 2005). Based  on its capacity to 
d irectly associate with the core subunit 11 (RPB11) of human PolII and  to transactivate a 
Gal4-linked reporter, AATF is thought to promote  cellular transcription as an adaptor or co-
factor (Fanciulli et al., 2000). Through its LxxLL motif, AATF can also bind  d irectly to nuclear 
hormone receptors and thereby enhance the activity of various steroid  receptors, such as 
androgen, estrogen, and  glucocorticoid receptors in a hormone-dependent manner 
(Burgdorf, Leister, & Scheid tmann, 2004).  
 
 
 
Figure 8. A schematic diagram of human Che-1/AATF protein structure. The N-terminal black 
boxes (amino acids 21-49 and  106-170) ind icate highly acid ic regions (A) which are separated  by a 
Ser/ Thr-rich d omain. The LZ box ind icates the leucine zipper domain located  betwee n amino acids 
239-260 (LZ). AATF contains 3 LXXL motifs, interaction motifs of coactivators for nuclear hormone 
receptors. The NLS boxes show putative nuclear localization signals. Phosphorylation of S141, S187, 
S474 and  S508 by Chk2 and  ATM/ ATR kinases promotes bind ing to p53 and  p21 promoter and  
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AATF also plays an important role in the DNA damage response. Upon genotoxic stress, 
ATM/ ATR and Chk2 phosphorylate human AATF, thereby protecting it from degradation 
(Tiziana Bruno et al., 2006). ATM/ ATR targets Ser187 of AATF whereas Chk2 
phosphorylates Ser141, Ser474 and Ser508 (Figure 7). At the same time,  phosphorylation of 
these sites promote AATF binding to the p21 and p53 promoters and consequently promote 
the transcription of these genes (Tiziana Bruno et al., 2006). Although phosphorylation of 
these sites is required  for recruitment of AATF to the p53 promoter, they are d ispensable for 
AATF binding to the E2F-target gene promoters. It has therefore been suggested  that a 
pathway involving AATF, p53, and  p21 might be a key component of the DNA damage 
checkpoints. However, a recent study showed that upon a genotoxic insult AATF 
phosphorylation by ATM/ ATR induces its translocation from the cytoplasm into the nucleus 
where AATF was shown to bind  and inhibit the induction of p53 targeted genes Bax, Bak and 
PUMA (Höpker, Hagmann, Khurshid , Chen, Hasskamp, et al., 2012).  
 
2.2. AATF role in apoptosis 
AATF was named based on its capacity to inhibit  apoptosis. Indeed, it seems that AATF has 
the capacity to bind  and regulate the activity of several apoptotic factors. The anti-apoptotic 
effect of AATF was initially described  through its antagonism of the DAP-like kinase (DLK) 
family of pro-apoptotic serine-threonine kinases (Page et al., 1999). DLK, also called  ZIP 
kinase, is found tightly associated  with nuclear PML bodies or with cytoplasmic actin 
filaments, where it induces apoptosis by enhancing the activity of Par-4, a leucine zipper 
protein which promotes neuronal death and aberrant production of β-amyloid  peptide (Aβ) 
(Guo & Xie, 2004). However, AATF may also antagonize Par-4 function, as the binding of 
AATF to Par-4 inhibits secretion of Aβ  in human neuroblastoma cells. Accordingly, AATF is 
found primarily mislocalized  in the cytoplasm in neuronal tissues from Alzheimer’ s patients 
(Guo & Xie, 2004). AATF also counteracts the activity of neurotrophin receptor-interacting 
MAGE homolog (NRAGE), a cytoplasmic protein involved in the regulation of apoptosis 
during neuronal development (Di Certo et al., 2007). In this case, NRAGE retains AATF in 
the cytoplasm and targets it for proteasome-dependent degradation. At the same time, AATF 
inhibits NRAGE-induced cell death, acting as a functional antagonist of NRAGE. AATF 
induces also the expression of Akt by cooperating with Stat3 during endoplasmic reticulum 
stress (ER stress) and  thereby promotes survival (Ishigaki et al., 2010). Another example in 
which AATF acts as an anti-apoptotic factor, is via induction of XIAP expression  (Bruno et 
al., 2008). As demonstrated  by Bruno and coworkers, in response to genotoxic stress AATF 
collaborates with NF-κB to induce XIAP expression and  this activity is required  for the anti-
apoptotic role of AATF in human colon carcinoma cell lines (Bruno et al., 2008). Lastly 
Höpker and coworkers have shown that AATF prevents apoptosis by inhibiting induction of 
p53-targeted  genes PUMA, Bax and  Bak by d irectly binding to their respective promoters 
(Höpker, Hagmann, Khurshid , Chen, Schermer, et al., 2012).   
 
3. Myoblast differentiation  
Skeletal muscle d ifferentiation is a complex, multistep process characterized  by the 
irreversible withdrawal of proliferating myoblasts from the cell cycle, the expression of 
muscle-specific genes, migration and fusion of plasma membranes to enable the formation of 
multinucleated  myotubes (Figure 8). In adult muscle tissue, myoblast proliferation, fusion 
and d ifferentiation are reactivated  upon injury and mimic the basic steps characterizing 
embryonal myogenesis. 
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3.1. Myogenesis – an overview  
Myogenic precursors are specified  during development by signals emanating from 
neighbouring cells of the notochord , neural tube, and dorsal ectoderm via the WNT and 
Sonic Hedgedog pathways as positive regulators, and via the BMP pathway and the Notch 
pathway as negative regulators. This specification depends critically on the function of 
myogenic transcription factors, such  as Pax3 and Pax7 (Borycki, Li, Jin, Emerson, & Epstein, 
1999; Cossu, Tajbakhsh, & Buckingham, 1996). Once committed , cells derived  from the 
somites, which are cell clusters generated by segmentation of the paraxial mesoderm, 
migrate to several sites of embryonic myogenesis, where they begin to express the myogenic 
basic helix-loop-helix transcription factors Myf5 and MyoD (Birchmeier & Brohmann, 2000) 
and to d ifferentiate into muscle fibers. Development of mouse limb muscles is characterised  
by two sequential waves of proliferation and migration of myoblasts , as well as fusion and 
d ifferentiation in muscle fibers. In the first stage, occurring between embryonic day (E) 11 
and E14, the first muscle fibers, commonly referred  to as primary fibers are formed 
(Buckingham et al., 2003). Several days later, during fetal development, secondary muscle 
fibers are added and allow  muscle growth to proceed. The secondary fibers derive from the 
proliferation of either a previously quiescent population of myoblasts (Cusella-De Angelis et 
al., 1994) or a population of Pax3-Pax7-positive progenitor cells (Relaix, 2006). Most likely, 
the somite-derived  myoblasts which do not d ifferentiate during development, constitute at 
least partially the adult muscle stem cells, named satellite cells (Gros, Manceau, Thomé, & 
Marcelle, 2005).  
 
In mature adult muscle, satellite cells are mitotically quiescent, but can be activated  in 
response to injury or d isease. Unlike embryonic myogenesis, muscle generation in higher 
vertebrates requires an extracellular matrix scaffold  on the injured  tissue for the formation of 
muscle fibers (Ciciliot & Schiaffino, 2010). Curiously, only amphibians and some fish are 
capable of regenerating muscle without a supportive and appropriate scaffold  tissue (Poss, 
2010). Satellite cells follow the same genetic hierarchy regulating embryonic myogenesis and 
can be identified  by the expression of specific markers such as m-cadherin, myocyte nuclear 
factor MNF, CD34 and Myf5. They also use asymmetric cell d ivisions for self-maintenance 
and to generate more committed  myogenic progenitors (Kuang, Kuroda, Le Grand, & 
Rudnicki, 2007; Shinin, Gayraud -Morel, Gomès, & Tajbakhsh, 2006). Indeed, upon activation, 
satellite cells proliferate, and  some of these will d ifferentiate and participate in the 
regeneration process, while a minor population  will reform the reservoir of satellite cells in 
the muscle (Shi & Garry, 2006) (Figure 9).  
 
3.2. Molecular components of myoblast differentiation  
The d ifferentiation of skeletal muscle in vitro is a well-known developmental and 
d ifferentiation model, characterized  by the sequential induction of various members of the 
MyoD basic helix-loop-helix transcription factor family (Pownall, Gustafsson, & Emerson, 
2002). Differentiation studies have largely made use of myoblast cell lines, such as the mouse 
C2C12 cell line, which is capable of inducible muscle d ifferentiation . Upon removal of 
mitogens, proliferating mononucleated  myoblasts stop d ivid ing and fuse into multinucleate 
myotubes through the sequential expression and combinatorial association between basic 
helix-loop-helix transcription factors (Massari & Murre, 2000) and myocyte-specific 
enhancer-binding protein MEF2 (Naya & Olson, 1999) (Figure 9). Proliferating myoblasts 
express the helix-loop-helix proteins MyoD and Myf5, which  bind   to MEF2 and histone 
deacetylase 1 (HDAC1) and thereby inhibit their activities (McKinsey, Zhang, & Olson, 
2002). Upon induction of d ifferentiation , MyoD is derepressed  and promotes the expression 
of another helix-loop-helix protein, myogenin, and  the cell-cycle regulators p21, cyclin D3 
and Rb. The induction of these key cell-cycle regulators and consequent dephosphorylation 
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of Rb allow cells to enter into a postmitotic state and d ifferentiation to proceed   (Novitch, 
Spicer, Kim, Cheung, & Lassar, 1999). Myf5 and MyoD are important determinants for the 
myogenic lineage while myogenin is essential for  muscle differentiation. In adult muscle, 
Myf5 is expressed  in quiescent satellite cell, while MyoD expression is induced upon 
activation and followed by myogenin as d ifferentiation begins (Figure 9).  Myogenin induces 
the expression of contractile proteins such as myosin heavy chain (MHC) and troponin  
(Beauchamp et al., 2000; Cooper et al., 1999). Other important players of muscle 
d ifferentiation are proteases such as caspase-3 and calpains whose activity is necessary for 
early initiation of the process, perhaps to allow cleavage and d isassembly of superfluous 
myoblast proteins and thereby make space for the expression of d ifferentiated  cell-specific 
proteins (Fernando et al., 2002; Liang, Yeh, Forsberg, & Ou, 2006).  
 
 
 
 
 
Figure 9. Schematic representation of adult myogenesis. Quiescent skeletal muscle satellite cells can 
be activated  upon injury or stimuli from the associated  fiber. Activated  satellite cells begin  to 
proliferate and  turn into myoblasts, which express the master regulators Pax3/ 7 and  the myogenic 
regulatory factors MyoD and  Myf5. The majority of myoblasts will d ifferentiate into myocytes, which 
stop cycling, lose expression of Pax3/ 7 and  Myf5, migrate, adhere and  fuse with each other and  to 
other myotubes to form large myotubes with many nuclei. A proportion of the cycling myoblasts w ill 
instead  reconstitute the reservoir of satellite cells (mod ified  from Le Grand  et al., 2007).  
 
 
3.3. Cdk5/p35 signaling 
Cyclin-dependent kinase 5 (Cdk5) is a small serine-threonine kinase which is structurally 
homologous to the cell cycle Cdks (Lew & Wang, 1995). Although Cdk5 binds to cyclin D 
and cyclin E (Guidato, McLoughlin, Grierson, & Miller, 1998; Xiong, Zhang, & Beach, 1992), 
there is no evidence that Cdk5 activity is regulated  by these cyclins (Morgan, 1997). Instead, 
activation of Cdk5 has been shown to be regulated  by the cyclin -related  proteins,, p35, and 
p39 (Dhavan & Tsai, 2001). Although Cdk5 is widely expressed  in mammalian tissues, its 
activators are expressed  mainly in neurons and during early stages of myogenesis (De 
Thonel et al., 2010; Lazaro et al., 1997; Sarker & Lee, 2004). Cdk5 and p35 participate in the 
development of neuronal cells and  axonal growth (Paglini et al., 1998; Pigino, Paglini, Ulloa, 
Avila, & Cáceres, 1997), and  are essential for neuronal migration in the cerebral cortex (Chae 
et al., 1997; Ohshima et al., 1996). In the brain, Cdk5 is not found in divid ing cells but is 
expressed  primarily in d ifferentiated  neurons. Hence, unlike other Cdks, Cdk5 does not 
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appear to participate in  cell cycling but is rather involved in regulating cell d ifferentiation 
and nuclear and  cytoskeletal processes (reviewed in Nguyen et al., 2002). Indeed, Cdk5 has 
been shown to be necessary and sufficient for neuronal cell cycle arrest and  subsequent 
d ifferentiation (Ohshima et al., 1996; T. Tanaka et al., 2001). Accordingly, analysis of the 
cortex of a Cdk5-deficient murine embryo has shown that nestin expression, a well-known 
marker for proliferative stem cell, remains elevated  also at an advanced stage of 
d ifferentiation and  typical d ifferentiation markers such as Map2 are absent (Cicero & 
Herrup, 2005).  
 
Cdk5 activity is necessary also for muscle d ifferentiation. Lazaro and coworkers showed that 
Cdk5 activity increases markedly during early stages of myoblast d ifferentiation. During this 
time, Cdk5 changes localization and moves from the cytoplasm to the nucleus. 
Overexpression of Cdk5 increases myogenic differentiation while inhibition of Cdk5 activity 
inhibits myogenesis in C2C12 cells, indicating that Cdk5 acts as a positive modulator of 
d ifferentiation (Lazaro et al., 1997). Our previous work identified  nestin as a target of Cdk5 
during myoblast differentiation where it functions as a scaffold  for the Cdk5/ p35 signaling 
complex. Upon activation, Cdk5 phosphorylates nestin at Thr316, thereby increasing the 
levels of unpolymerized  nestin and allowing the reorganization of nestin into parallel fibers 
(Sahlgren et al., 2003). Our more recent study further clarifies the role of nestin in 
determining the amount of active Cdk5/ p35, and  thereby regulating the d ifferentiation 
process. Indeed when nestin was overexpressed , it strongly promoted  myogenesis, whereas 
myogenesis was inhibited  by nestin downregulation (Pallari et al., 2011). 
 
3.3.1. The Cdk5 activator, p35 
p35 is a highly unstable protein with a half-life of 20-30 minutes as determined in rat cortical 
neurons (Patrick, Zhou, Kwon, Howley, & Tsai, 1998). p35  can be cleaved between residue 
Phe-98 and Ala-99, resulting in the removal of the N -terminal fragment (amino acids 1-98) 
and in the formation of the more active and  more stable fragment p25 (Uchida et al., 1994) 
(Patrick et al., 1998). The cleavage of p35 removes the myristoylation signal located  in the N-
terminal end , and  shifts the Cdk5/ p35 complex from a membranous to a cytoplasmic 
localization (Figure 10) (Kusakawa et al., 2000; Patrick et al., 1999). The p25 fragment can also 
target Cdk5 to the nucleus where Cdk5 has been shown to phosphorylate and regulate the 
activity of several transcription factors, such as the pro-survival factor MEF2 (P. D. Smith et 
al., 2006) and the tumor suppressor p53 (Zhang et al., 2002). Even though the generation of 
p25 has been generally associated to apoptosis in several neuronal systems (Hamdane et al., 
2005; O’Hare et al., 2005; P. D. Smith et al., 2006), it is not clear whether it is the elevated 
Cdk5-p25 activity or the change in localization and target proteins which mediate cell death.  
Calpain was identified as the enzyme responsible for the cleavage of p35 (Kusakawa et al., 
2000; M. S. Lee et al., 2000). Indeed, calpain inhibitors reduce or completely abolish 
conversion of p35 to p25 (M. S. Lee et al., 2000; Patzke & Tsai, 2002). As calpains are calcium-
activated proteases involved in hypoxic/ ischemic and other neuronal cell death paradigms, 
calcium homeostasis is likely to be crucial in the regulation of Cdk5 activity, especially under 
pathological conditions characterized often by a d isrupted  calcium homeostasis. It also 
seems that phosphorylation of p35 at Ser8 and Thr138 by Cdk5, protects p35 by calpain -
mediated  cleavage and that dephosphorylation of Thr138 is critical to allow p25 formation 
(Kamei et al., 2007). 
 
 
 
Review of the Literature
  
30 
 
 
 
 
Figure 10. Schematic representation of the mechanism of regulation of Cdk5. Binding of the 
activator p35 to Cdk5 targets the complex to membraneous fractions of the cell. Upon calpain 
activation, p35 is cleaved  into the more active fragment p25 and  loses its myristoylation signal. The 
Cdk5/ p25 complex is activated  and  d istributes into the cytoplasn and  nucleus where it targets 
d ifferent substrates. 
 
 
 
3.3.2. Cdk5 targets and functions 
As an exception within the Cdk family, Cdk5 does not seem to be involved in cell cycle 
progression, although it can bind  and phosphorylate the Rb protein (Honma, Hosono, 
Kishimoto, & Hisanaga, 1997). Instead , several other biological functions have been 
described  for Cdk5. Many Cdk5 target proteins are cytoskeletal proteins, kinases involved in 
cytoskeletal regulation or neuronal migration, cell adhesion molecules involved in 
membrane cycling and axonal transport, such as neurofilaments, MAP1B, c-Abl, cables, 
PAK1, Src, Nudel, b-catenin (Kesavapany et al., 2001; Niethammer et al., 2000; Paglini et al., 
1998; Sun, Leung, & Liem, 1996; Zukerberg et al., 2000). A common function of these 
d ifferent Cdk5 targets is the regulation of cell morphology and motility, including neuronal 
migration, axonal outgrowth and axonal transport. Therefore, n ot surprisingly, the targeted 
d isruption of Cdk5 induces a prenatally lethal phenotype caused  by a CNS dysfunction 
(Ohshima et al., 1996, 1999). Cdk5-deficient mouse embryos show a widespread  d isruption of 
cortical layering, again suggesting a role for Cdk5 in neuronal migration. Interestingly and 
accordingly, double knockout of p35 and of the second major Cdk5 activator p39 result in a 
phenotype identical to Cdk5-deficient mice (Ko et al., 2001). Some studies also suggested  a 
role for Cdk5 in dopamine signaling and in the regulation of drug a ddiction upon cocaine 
administration (Bibb et al., 2001; White & Cooper, 2001). Two other studies showed that 
NMDA receptors are another target of Cdk5 and that their phosphorylation results in 
decreased  long-term potentiation and regulate neuronal plasticity and cognitive functions (Li 
et al., 2001; Fischer et al., 2002). 
 
In addition to neuronal morphology and migration, Cdk5 activity has been associated  to 
neuronal cell death, such as  in neurons  subjected  to excito-toxins, β-amyloid , and  oxidative 
stress (Alvarez, Toro, Cáceres, & Maccioni, 1999; Gong et al., 2003; M. S. Lee et al., 2000), as 
well as in animal models of stroke (J. Wang, Liu, Fu, Wang, & Lu, 2003), Parkinson’s d isease 
(P. D. Smith et al., 2003), and  amyotrophic lateral sclerosis (Nguyen, Larivière, & Julien, 
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2001). Importantly, each of these models is thought to involve deregulated  Ca
2+
 signaling and 
d isplay elevated  production of the cleaved fragment p25, which is almost non-detectable 
under physiological conditions (Lee et al, 2000). Indeed, Cdk5 has been shown to promote 
cell death when its activator p35 is cleaved into the smaller and  more active form p25 by 
calpains (Kusakawa et al., 2000; M. S. Lee et al., 2000; Patrick et al., 1999) (Figure 10). 
Accordingly expression of Cdk5/ p25 induces apoptosis in primary cortical neurons (Patrick 
et al., 1999; Gon et al., 2003). Cdk5/ p25 has been shown to increase the levels of phospho-
Tau while a dominant -negative Cdk5/ p25 abolishes Tau phosphorylation in cortical 
neurons (Ahlijanian et al., 2000; Patrick et al., 1999). Accordingly, overexpression of p25 in 
transgenic mice results in neurodegenerative phenotype including formation of paired 
helical filaments, Tau aggregation and neuronal loss similar to that observed in Alzheimer's 
d isease (Pei et al., 1999; Patrick et al., 1999; Tseng at al., 2002). Also, p25 formation enables 
the shuttling of Cdk5 into the nucleus where Cdk5 phosphorylates and inhibits the pr o-
survival transcription factor MEF2. Phosphorylation of MEF2 has been demonstrated  to 
make cortical neurons more sensitive to oxidative stress (Gong et al., 2003; O’Hare et al., 
2005; P. D. Smith et al., 2006). Other nuclear targets of Cdk5 are the survival factors p53 and 
Rb. Excessive Cdk5 activity can indeed  contribute to neuronal cell death via phosphorylation 
of p53 (Zhang, Krishnamurthy, & Johnson, 2002) and Rb (Hamdane et al., 2005). In fact, 
Cdk5-mediated phosphorylation of p53 d isrupts the binding to the E3 ubiquitin ligase 
Hdm2, thereby increasing p53 protein levels (Lee et al., 2007). Furthermore, Cdk5-mediated 
phosphorylation promotes the acetylation and transcriptional activivation of p53, and 
consequently the induction of pro-apoptotic genes (Lee et al., 2007). Despite the large 
number of data linking the induction of apoptosis to increased  Cdk5 activity and p25 
accumulation, the conditions which tu rn Cdk5 into an active effector of neuronal death 
remain unclear and  are mainly attributed  to the cleavage of the regulator p35. 
 
3.4. Atypical PKCs 
The protein kinase C (PKC) family is formed by 10 d ifferent lipid -dependent 
serine/ threonine kinases (PKCα, βI, βII, γ , δ , ε , η, θ , ξ  and λ / ι ) which have been implicated  
in a wide range of cellular processes, such as cell growth, transcription, immune responses, 
membrane structure regulation, learning and memory  (Breitkreutz, Braiman-Wiksman, 
Daum, Denning, & Tennenbaum, 2007; W. S. Liu & Heckman, 1998). PKCs exhibit d istinct 
tissue d istribution: PKCα, β, δ , ε  and  ξ  are ubiquitously expressed , PKCγ  is restricted  to the 
central nervous system and spinal cord , PKCη is strongly expressed  in the skin and in the 
lung, PKCθ  in the skeletal muscle tissue, and  PKCη  in numerous tissues and strongly in the 
thymus and lung.  
 
The structure of PKC isozymes includes conserved domains refer red  to as C1-C4, interrupted 
by variable regions V1-V5 of unknown function (Figure 10). The C1 region, located  close to 
the N-terminal, contains two main motifs. One resembles the consensus sequence found in 
the phosphorylation sites of major PKC substrates, except for having an alanine residue in 
place of a serine or threonine as a phospho-acceptor and thereby blocking the substrate-
binding site of the kinase. This motif serves as an autoregulatory domain, referred  to as 
pseudo-substrate (PS). The second motif of the C1 domain contains two cysteine-rich 
sequences, important to mediate binding to d iacylglycerol (DAG) and phorbol esters. The 
atypical PKCs (aPKC) d iffer in this region because they possess only half of the C1 domain 
and therefore, cannot be activated  by C1 ligands such as DAG and phorbol esters (Figure 11). 
The C2 domain contains many acid ic amino acids which are thought to participate in 
binding to Ca2+. The C-terminal regions, C3-V5, constitute the catalytic domain. The C3 
region contains the ATP binding sequence similar to the one present in other protein kinases.  
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Finally, the C4 domain contains the substrate-binding region and the phosphate-transfer site 
(Figure 11).  
 
According to their structure and mode of activation, the PKC superfamily has been 
subdivided  into three subgroups: 1) the conventional PKC isoforms (cPKC), including PKCα, 
PKCβ and PKCγ  that are activated by d iacylglycerol (DAG) and Ca2+; 2) the novel PKC 
isoforms (nPKC) (PKCδ , ε , η, θ ) that are only sensitive to DAG but not to Ca2+; 3) the 
atypical PKC isoforms (aPKC), the PKCξ  and PKCλ/ ι , that are neither sensitive to DAG nor 
to Ca2+ (Parker & Murray-Rust, 2004) (Figure 11).  
All three subgroups are regulated  by phosphatidylserine, 3’-phospho-inositide-dependent 
kinase-1(PDK1), and  auto-phosphorylation (Newton, 2001).  
 
 
 
 
 
 
 
 
Figure 11. Structural characteristics of the PKC family 
Each PKC contains a highly homologous C-terminal catalytic domain and  an N -terminal regulatory 
domain. The DAG/ phorbol-ester-bind ing C1 domain, which is constituted  of two repeated  cysteine-
rich zinc-finger motifs (C1A and  C1B), is functional in the conventional PKCs (cPKC) and  in the novel 
PKCs (nPKC) but not in the atypical PKC (aPKC). The C2 d omain mediates Ca
2+
 bind ing in cPKCs, but 
d ifferences in the key residues abrogate this function in nPKCs. aPKCs have single modified  C1 
domain and  hence cannot bind  to Ca2+. C3 and  C4 form the ATP- and  substrate-bind ing regions of 
the kinase core. The autoinhibitory pseudosubstrate sequence (PS) interacts d irectly with the 
substrate-bind ing cavity in the catalytic d omain, thereby sterically  blocking access of substrates to the 
active site.  
 
 
The atypical PKCs are involved in a wide range of physiological processes including 
mitogenesis, protein synthesis, cell survival and  transcriptional regulation. The two sub -
family members, PKCξ  and PKCλ/ ι , are highly related , with a 72% overall amino acid 
identity (Nishizuka, 1995). The main sequence divergence is in the last 60-residues segment 
of the N-terminal regulatory domain. PKCξ  deficient mice are viable but show impaired NF-
κB signaling and immune response (Leitges et al., 2001; P. Martin et al., 2002). Instead , 
PKCλ -deficient mice die at an early embryonic stage (Akimoto et al, unpublished results). 
The d ifferential contribution of these two isotypes might be due to their different expression 
levels and tissue d istribution but isoform-specific roles have been difficult to identify due to 
the high sequence similarity between PKCξ  and PKCλ . Indeed all aPKC binding proteins 
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reported  so far bind  to both aPKC isoforms or at least binding exclusivity to one isoform has 
not been demonstrated . 
 
3.4.1. PKCξ  activation mechanism 
The mechanism of activation of aPKC primarily consists of two events: the release of the 
autoinhibitory domain and the phosphorylation of the kinase domain (Newton, 2001). The 
PKC C1 domain contains an autoinhibitory pseudosubstrate sequence that keeps the enzyme 
in an inactive form by masking one or more phosphorylation site(s). Interaction with 
membrane lipids and metabolites, such as phosphatidylserine and DAG, induce the release 
of the pseudosubstrate from the active site in conventional and  novel PKCs, while interaction 
with lipid  components, such as arachidonic acid and ceramide, promotes the release of the 
pseudosubstrate in the atypical PKCs (W. S. Liu & Heckman, 1998). After the release of the 
pseudosubstrate, PDK-1 phosphorylates the activation loop of PKC members (Balendran, 
Hare, Kieloch, Williams, & Alessi, 2000; Le Good et al., 1998). PDK-1 phosphorylates Thr410, 
which is essential for PKCξ  activation. Following Thr410 phosphorylation, Thr560 is targeted 
by PKCξ  autophosphorylation, leading to a complete activation of the kinase (Le Good et al., 
1998; Standaert, Bandyopadhyay, Kanoh, Sajan, & Farese, 2001). PKCξ  is activated  by several 
lipid  groups, including phosphatid ic acid  (Nakanishi & Exton, 1992), phosphatidylinositol 
3,4,5-triphosphate (Nakanishi, Brewer, & Exton, 1993), arachidonic acid  and ceramide 
(Müller et al., 1995). Consistently, aPKCs are strongly implicated  as downstream effectors of 
PI 3-kinase (Chou et al., 1998; Sontag, Sontag, & Garcia, 1997; Takeda et al., 1999). Protein-
protein interactions play a major role in restricting the localization and the activation of 
aPKC and are therefore described  in more detail in the following paragraph  (Moscat et al., 
2000). 
 
3.4.2. Regulation of aPKC activity through protein-protein interaction 
A key event in PKCξ  activation and in the engaged signaling pathway relies on the 
association of PKCξ  with other signaling molecules and scaffold  proteins that mediate 
transport and  shuttling to d istinct subcellular sites or act as anchors to allow the for mation of 
oligomeric signaling complexes. Here below are listed  the most well-known aPKC 
interacting domains and the respective binding molecule and the activated pathway: 
 
 PB1 domain  
The PB1 domain is a conserved structural module of about 80 amino acids that mediates 
protein-protein interaction between signaling molecules (T. Ito, Matsui, Ago, Ota, & 
Sumimoto, 2001). The PB1 domain of aPKC serves to locate aPKCs into d istinct subcellular 
regions and signaling complexes and is located  in the V1 region which is conserved among 
the aPKCs but shows no similarity to other PKC isoforms (T. Ito et al., 2001; D. Lin et al., 
2000). For example, p62/ ZIP, an SH2-interacting protein, acts as a scaffold  to recruit aPKC 
into d ifferent signaling complexes, such as the TNFα receptor complex or the IL-1 complex, 
where aPKC can phosphorylate and regulate IKKβ (Sanz, Diaz-Meco, Nakano, & Moscat, 
2000; Sanz, Sanchez, Lallena, Diaz-Meco, & Moscat, 1999). P62/ ZIP can promote the 
recruitment of aPKC also to the NGF receptor complex where it mediates cell survival 
(Wooten, Seibenhener, et al., 2001). aPKCs can also utilize their PB1 domain to interact with 
the partitioning proteins PAR-3 and -6, determinants of asymmetric cell d ivision and 
polarized  cell growth (Tabuse et al., 1998; Hung and Kemphues, 1999). PAR-6 targets aPKC 
to the small GTPases of the Rho family, Rac1 and Cdc42, in a GTP-dependent manner. 
Binding of PAR-6 only usually causes the suppression of PKC kinase activity, while  
association of Rac1/ Cdc42 to PAR-6 relieves the suppression of aPKC (Joberty, Petersen, 
Gao, & Macara, 2000; D. Lin et al., 2000; Qiu, Abo, & Steven Martin, 2000; Suzuki et al., 2001). 
Therefore, Cdc42 functions as an activator of the PAR-6/ aPKC complex. The PAR-
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6/ aPKC/ Cdc42 complex has been shown also to interact with the glycogen synthase kinase-
3β  (GSK-3β) and  thereby to promote the polarization of the centrosome and the d irection of 
cell protrusion (Etienne-Manneville & Hall, 2003). In this context, the PAR-6/ aPKC/ Cdc42 
complex phosphorylates and inactivates GSK-3β  at the edge of a migrating cell and  allows 
the establishment of cell polarity. PKCξ  can interact via its PB1 domain also with MEK5, 
functioning as an adapter in the MEK5/ ERK5 pathway, a MAPK cascade critically involv ed 
in mitogenic activation by EGF (Diaz-Meco & Moscat, 2001). PKCξ  in this case is essential to 
promote ERK5 activity and interestingly it does so by functioning as an adapter independent 
of its enzymatic activity. 
 Cysteine-rich domain  
The single cysteine-rich domain located in the C1 conserved region of aPKC interacts with 
PAR-4 (prostate androgen response-4), whose expression is induced during apoptosis. PAR-
4 binds to the single cysteine-rich sequence of aPKC and thereby inhibits the aPKC kinase 
activity independently of lipid  binding. This results in the suppression of the pro-survival 
role of aPKC and enhancement of apoptosis (Díaz-Meco et al., 1996).  
 PXXP motif 
Wooten and coworkers have shown that Src uses its SH -3 domain to bind  to PXXP-rich 
sequences located  between the C1 and the PB1 domain of aPKCs (Wooten, Vandenplas, 
Seibenhener, Geetha, & Diaz-Meco, 2001). This association is enhanced by NGF treatment 
and promotes the formation of a complex containing the NGF receptor TrkA, Src and  PKCι . 
PKCι  interacts with active but not with inactive Src which, in turn, phosphorylate PKCι  at 
different sites. It has been proposed that phosphorylation of specific aPKC tyrosine residues 
by Src may d ictate the type of interaction and the component of the binding proteins, and 
thereby the type of engaged signaling pathway.  
 
 
3.4.3. PKCξ  targets and functions  
An increasing number of studies indicate that the aPKC isoforms are critically involved in a 
number of important cellular functions, such as the regulation of cell proliferation and 
survival, and  neuronal and  leukemic d ifferentiation. Here below are listed  the most well-
known functions. 
 
Upon activation by ceramide or by NGF treatment, PKCξ  translocates from the cytoplasm to 
the nucleus and regulates both differentiation and cell survival of neuronal cells (Calcerrada 
et al., 2002; White et al., 2002; Wooten et al., 1997). Upon nuclear entry, PKCξ  locates to the 
inner nuclear matrix where it binds ch romatin and p lays critical roles in regulation of 
transcription, ribosomal RNA biosynthesis and  shuttling of mRNA . Several nuclear targets 
of PKCξ  have been identified  including SP1 (Pal, Claffey, Cohen, & Mukhopadhyay, 1998), 
NF-κB (A. G. Martin, San-Antonio, & Fresno, 2001), nucleolin (Zhou, Seibenhener, & 
Wooten, 1997), and hnRNP A1 (Municio, Lozano, Sánchez, Moscat, & Diaz-Meco, 1995). 
PKCξ  mediates cytoprotection against drug- or UV-induced apoptosis (Huang, Ma, Bowden, 
& Dong, 1996; Jamieson, Carpenter, Biden, & Fields, 1999). In these cases, ceramide, 
produced under various apoptotic stimuli, may work as a second messenger to activate 
PKCξ  (Lozano et al., 1994). Furthermore, PKCξ  has been reported  to be a substrate for 
several caspases (Smith et al., 2000). Interestingly, the other atypical PKC, PKCλ , is resistant 
to caspase-mediated  cleavage as it does not have a caspase processing site. Caspase -3, -6,-7, 
and  -8 cleave PKCξ  in the hinge region between the regulatory and catalytic domains and 
generate a free kinase domain fragment (Lucinda Smith, Wang, & Smith, 2003). Also, PKCξ  
has been reported  to regulate the NF-κB pathway by phosphorylating IκB and p64 subunit 
(Rel A) at Ser311 residue and, thereby, mediating the anti-apoptotic role of NF-κB (Duran, 
Diaz-Meco, & Moscat, 2003; Savkovic, Koutsouris, & Hecht, 2003). PKCξ  is also 
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indispensable for the establishment of epithelial cell polarity. The polarity protein PAR-3 was 
identified  as an interacting protein of PKCξ  (Izumi et al., 1998). PAR-3 binds to a 
transmembrane component of the tight junctions (JAM) and recruits the PKCξ / PAR-6 
complex to it (Nagai-Tamai, Mizuno, Hirose, Suzuki, & Ohno, 2002). PKCξ  is therefore 
necessary to establish the asymmetric submembranous structures which enable the 
subsequent organization of cell polarity. Defect in one of the protein complex causes the 
mislocalization of the other proteins and the d isruption of cell polarity. The downstream 
targets of aPKCs for the establishment of epithelial cell polarity are still unknown (Nagai-
Tamai et al., 2002). Interestingly, aPKCs are present only in multicellular organisms, for 
which establishment of cell polarity is essential, suggesting that the appearance of aPKCs 
might have been a critical event for the development of multicellular organisms  (Suzuki et 
al., 2001). PKCξ  also participates in protein transport by recruitment to the pre-Golgi 
compartment through association with the small GTPase Rab2. Inhibition of PKCξ  blocks 
Rab2-mediated  reverse translocation  and results in an accumulation of swollen vesicles at 
the pre-Golgi compartment, suggesting that PKCξ  modulates recycling cargos (Tisdale, 
Wang, Silver, & Artalejo, 2003). Lastly several studies have demonstrated  that active PKCξ , 
the processed  catalytic fragment (PKMξ ), is necessary and sufficient for maintenance of long 
term potentiation (LTP) and memory but its downstream targets remain to be identified  
(Drier et al., 2002; Ling et al., 2002).  
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OUTLINE OF THE STUDY 
 
A timely area of research is the crosstalk between signals that regulate survival, cell stress, 
d ifferentiation, and  programmed cell death. Often the same signaling factors can be involved 
in regulating several processes, depending on the context at which they are activated . In this 
regard , I was especially interested in AATF and Cdk5, as both of these signaling molecules 
form multitasking complexes, in a way like operational joysticks on the road  to cellular fate.  
 
The starting point of this project was based  on our and other previous works which 
identified  both Cdk5/ p35 and PKCξ  as positive and independent regulators of the 
differentiation process.  The goal of my study was to investigate whether these two kinases 
were regulating the same signalling cascade pathway and whether one was the  upstream 
regulator of the other.  
Furthermore, I was intrigued by a novel and  unexplored  transcription factor involved in the 
regulation of stress responses and apoptosis, AATF, which was shown to have both the 
property of promoting cell proliferation and  inducing cell cycle arrest. During the course of 
this work, I cloned several AATF isoforms from different murine tissues and investigated the 
role of AATF in response to apoptotic insults such as UV irradiation. In summary the aims of 
this thesis were: 
 
- To characterize the role and target of AATF upon an apoptotic insult. 
- To identify upstream regulators of the Cdk5/ p35 complex during muscle 
d ifferentiation. 
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EXPERIMENTAL PROCEDURES 
 
1. Plasmid constructs (I-III) 
Plasmids encoding c-Jun-HA, Gal4-c-Jun, Gal4-c-JunAA, and Gal4-c-JunΔ have been 
described  earlier (Ferraris et al., 2012; Weiss et al., 2003; Westermarck et al., 2002). p35 and 
Cdk5 cloned into pcDNA3.1 His vectors were kindly provided by Dr. Harish Pant (National 
Institutes of Health, Bethesda, USA). Myc-tagged p35 was purchased  from Addgene. Pint 
mutation to this vector was made using QuickChange site-directed  mutagenesis kit 
(Stratagene) and verified  by sequencing. The Flag-tagged PKCζ  and PKCι  were kindly 
provided by Dr. John Blenis (Harvard  Medical School, Boston, USA). The following 
procedure was followed to clone AATF into EGFP vector. RNA was isolated  following 
standard  techniques (Trizol) from murine muscle, brain, lung tissues and retro -transcribed 
into cDNA using random primers and RT accord ing to the manufacturer’s instructions. The 
following primer pairs were used  in order to amplify and clone AATF isoform 1, 2 and 3 
from cDNA into EcoRI and KpnI sites in -frame with the C-terminal EGFP tag in EGFP-C1 
vector or with the N-terminal EGFP tag in EGFP-N3 vactor.  
 
Forward  primer for AATF1 and 2 (cloning into EGFP-C1): 
5’GCGAATTCTATGGCGGCGCCGCAGCCCTTG3’; 
Reverse primer: 
5’CCGGTACCTCACTTCCCACGGTCTGCATC3’; 
 
Forward  primer for AATF1 and 2 (cloning into EGFP-N3): 
5’GCGAATTCTATGGCGGCGCCGCAGCCCTTG3’; 
Reverse primer for AATF1 and 2: 
5´GACGGTACCCTTCCCACGGTCTGCATCAGG3´; 
 
Forward  primer for AATF3 (cloning into EGFP-C1): 
5’GCGAATTCTATGGCGGCGCCGCAGCCCTTG3’; 
Reverse primer for AATF3: 
5´CCGGTACCGAGCTGGTGGTAAAAGTCATC3´ 
 
2. Cell culture (I-III) 
All cell lines were maintained  in a humified  5% CO2 atmosphere at 37°C. HEK293 and Hela 
cells were cultured  in Dulbecco’s modified  Eagle’s medium (DMEM; Sigma), containing 10% 
fetal bovine serum (FBS), 2mM L-glutamine, and  antibiotics (penicillin  and streptomycin). c-
Jun-KO MEFs and wt MEFs were cultured  in DMEM containing 10% FBS, 2 mM L-
glutamine, 1 mM sodium pyruvate.   
 
C2C12 cell line is a subclone from a mouse myoblast cell line isolated  from the thigh muscle 
of an adult mouse (Yaffe and Saxel, 1977). This cells line was m aintained  in DMEM 
supplemented  with 10% FBS, 2mM Glutamine, and  antibiotics (growth medium). 
Differentiation of C2C12 myoblasts was induced by replacing growth medium with DMEM 
supplemented  with 1% FBS, 2mM L-Glutamine, and  antibiotics (d ifferentiation med ium).  
 
3. Experimental treatments (I-III) 
The inhibition of PKCξ  activity was achieved by addition to the growth o r d ifferentiation 
medium of 15-20 μM PS peptide inhibitor  (PS; Myr-SIYRRGARRWRKL; MilleGen Prologue 
Biotech). Scramble peptide (Scr-P;Myr-RLYRKRIWRSAGR) was used  as a control to exclud e 
unspecific effects due to peptide treatments. Calphostin C was used  to specifically inhibit the 
cPKCs and nPKCs. To inhibit Cdk5 activity Roscovitine was added to the medium at 10 μM. 
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JNK inhibitor SP-600125 was used  at 20 μM. Calpain activity was induced by adding 10 μM 
of calcium ionophore A23187 (Calbiochem). The inhibition of calpain activity was obtained 
with 15 μM calpain inhibitor III (Calbiochem).  
 
For UV irradiation, cells were left to grow until they reached 80% confluency. Medium was 
removed and cells were rinsed  once with PBS. Cells were than exposed to UVC irradiation, 
with an intensity of 15-20 μJ for MEF cells and  100-120 μJ for HEK293 cells. Immediately after 
irrad iation, PBS was replaced  with warm growth medium and cells were further incu bated 
for further analysis. 
 
4. Isolation and culture of primary myoblasts (III) 
Primary myoblasts cultures were established  from the limb of newborn mice. Muscle tissue 
was minced and enzymatically d igested  by incubation in 0.2% type XI collagenase (Roche 
Diagnostics) and  0.1% trypsin at 37°C for 45 minutes. The resulting slurry was filtered  to 
remove large pieces of tissue and rinsed  with growth medium (Hams F-10 [Sigma] 
supplemented  with 15% FBS, 2 M L-glutamine, antibiotics, and  2.5 ng/ ml fibroblast growth  
factor-β  [Promega]). Cells were centrifuged at 1000 x g for 5 min, resuspended in growth 
medium, and plated  into tissue culture d ishes. When cells reached 80% of confluence, 
d ifferentiation was induced by replacing growth medium with d ifferentiation mediu m 
(DMEM supplemented  with 1% FBS, 2mM L-Glutamine, and  antibiotics). 
 
5. Transfections (I-III) 
Hela and HEK293 cells were transfected  by electroporation. For this purpose, approximately 
5X10^ 6 cells were collected , centrifuged and resuspended in 0.4 ml of Opt iMEM (Gibco). 
After addition of 20-40 µg plasmid  DNA, cells were transferred  in 0.4 cm electroporation 
cuvettes (BTX) and subjected  to single electric pulse (220 V, 975 μF) using a Bio -Rad Gene 
Pulser electroporator. Electroporated  cells were than resuspended in growth medium and 
plated . Expression of transfected  plasmids was assessed  after 24-48 hours.  
 
C2C12 and mouse primary myoblasts were transfected  using the Lipofectamine plus reagent 
(Life Technologies) according to manufacturer’s instructions.  
The downregulation of PKCξ  was achieved by transfecting cells with 20 or 80 pmol of PKCξ  
siRNA pool (Santa Cruz Biotechnology) using Lipofectamine plus reagent. AATF was 
downregulated  using AATF siRNA or scrambled  siRNA (Qiagen), transfected  with 
Lipofectamine RNAiMAX reagent (Life Technologies) according to manufacturer’s 
instructions. 
  
6. Western blotting (I-III) 
Cell extracts were prepared  by lysis in Laemmli buffer, subjected to SDS-polyacylamide gel 
electrophoresis (SDS-PAGE) and transferred  to nitrocellulose membrane (Protran 
nictrocellulose, Schleicher & Schuell) using semidry or wet transfer apparatus (Bio-Rad, GE 
Healthcare). Membranes were blocked with 5% non -fat milk in PBS containing 0.3% Tween-
20 for 1 h at RT. Western blotting were performed using antibodies against AATF (used  at 
1:500; Cell Signaling Technology), c-Jun (1:500; Santa Cruz Biotechnology), phS63 c-Jun 
(1:1000; Cell Signaling Technology), GFP (1:5000; JL-8, Living Colors), nestin (BD 
Pharmigen), p35 (1:1000; C-19 and N-20, Santa Cruz Biotechnology), Cdk5 (1:1000; DC34, 
Biosource Invitrogen and C-8, Santa Cruz Biotechnology), PKCζ  (1:500; Santa Cruz 
Biotechnology), poly(ADP-ribose)polymerase (1:1000; PARP; Sigma), p21 (1:1000; C-19, Santa 
Cruz Biotechnology), myogenin (1:500; M-225, Santa Cruz Biotechnology), troponin (1:500; 
JLT-12, Sigma), MHC (1:1000; H-300, Santa Cruz Biotechnology), desmin (1:500; RD301, 
Santa Cruz Biotechnology), calpain 1 (1:1000; Cell Signaling Technology), calpain 3 (1:500; 
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Abcam), RhoA (1:200; Santa Cruz Biotechnology), 14-3-3τ  (1:1000; Santa Cruz 
Biotechnology), HSC70 (1:10,000; SPA-815, Stressgen), actin (1:1000; AC-40, Sigma). After 
washed with 0.3% Tween-20 in PBS, membranes were probed with horseradish peroxidase-
conjugated  secondary antibodies (used  at 1:10,000; Promega, Southern Biotechnology, an d 
GE Healthcare). Proteins were visualized  using ECL detection kit (GE Healthcare). 
 
7. Co-immunoprecipitation analyses (I-III) 
Cells were harvested , suspended in lysis buffer (50 mM HEPES, pH 7,4, 140 mM NaCl, 5 mM 
EDTA, 0.4% NP40, 0.1% Triton, 10 mM pyrophosphate, 1 mM dithiothreitol [DTT], 5 mM 
sodium orthovanadate, and  a protease inhibitor cocktail [Roche Diagnostics, Basel, 
Switzerland]) and  kept on ice for 20 min , followed by centrifugation at 10,000 × g for 10 min 
at 4°C. For AATF or c-Jun immunoprecipitation, lysates were first sonicated  and centrifuged 
at 13.000 g for 10 min at 4°C. Supernatant protein concentration was measured  by Bradford  
assay. 800 µg of protein lysate  was used  for immunoprecipitation with the indicated  
antibodies under rotation overnight at 4°C. Immuno-complexes were captured  with 50% 
slurry of protein A-sepharose at 4°C on a rotamix for 1 h. the beads were centrifuged and 
washed 4 times with 20 mM HEPES (pH 7.4), 2 mM EDTA, 100 mM NaCl, 0.4% NP40, and 1 
mM DTT and finally resuspended in Laemmli sample buffer. Immunoprecipitated  proteins 
were eluted  from the beads by boiling for 5 minutes in Laemmli buffer, run on a SDS-PAGE 
and detected  by western blotting.  
 
8. Kinase activity assays (III) 
Cdk5 or PKCζ  were immunoprecipitated  from differentiating myoblasts. Cells were lysed  in 
50 mM HEPES (pH 7,4), 140 mM NaCl, 5mM MgCl2, 5 mM EGTA, 0.4% NP-40, 10 mM 
pyrophosphate, 1 mM DTT, 5 mM sodium orthovanadate, and  a protease inhibitor cocktail 
(Roche Diagnostics, Basel, Switzerland). Lysates were centrifuged at 10.000 g for 10 min at 
4°C, supernatants were collected  and protein concentration was measured  by Bradford 
assay. 800 µg of protein per lysates was precleared  with protein G-sepharose prior to 
immunoprecipitation with anti-PKCζ  or anti-Cdk5 antibodies on a rotator at 4°C overnight. 
After 1 h incubation with protein G-sepharose beads, the immunoprecipitates were collected 
by centrifugation and washed 4 times in 50 mM HEPES (pH 7,4), 125 mM NaCl, 5mM 
MgCl2, 5 mM EDTA, 0.2% NP-40, 1 mM (DTT), and  twice in 50 mM HEPES (pH 7,4), 25 mM 
NaCl, 0, 1 mM DTT. For PKCζ  activity beads were resuspended in PKCζ  kinase buffer (50 
mM Hepes [pH 7.4], 1mM EDTA, 1mM DTT, 10 mM MgCl2) and for Cdk5 activity in Cdk5 
kinase buffer (50 mM Tris-HCl [pH 7.4], 5mM MgCl2, 1mM EDTA, 1 mM DTT). The 
resuspended beads were incubated  with histone1 (3µg), 200 µM ATP and 10 µCi of γ -32P 
ATP for 30 min at 32°C (PKCζ ) or at 25°C (Cdk5) and stopped by addition of Laemmli buffer 
and boiling for 5  minutes. Samples were run on a SDS-PAGE and subjected  to 
autoradiography. 
 
9. Calpain assays (III) 
The brains of newborn mice were isolated  and homogenized  in lysis buffer (20 mM Hepes 
pH 7.4, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM EGTA) using a Teflon g rinder (Sato et 
al., 2007). The homogenates were centrifuged at 13000 x g for 25 min at 4 °C. Pellets were 
resuspended in 100 µl of lysis buffer, sonicated , and  centrifuged again at the same 
conditions. The supernatants were d ivided  into control and  treated  sample. Calpain activity 
was induced by adding CaCl2 at a final concentration of 4 mM and incubating for 1 h at 
37°C. The reaction was stopped by adding 10 mM EGTA and an equal volume of Laemmli 
sample buffer. The cleavage of p35 was assessed  by western blotting. 
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10. Luciferase reporter assay (I-II) 
24 h after transfection, cells were harvested  and lysed  in Passive lysis buffer (Promega) 
according to manufacturer´s instructions. Cell lysates were centrifuged (15,000 x g for 2min) 
and the supernatants were collected . The firefly luciferase activity produced by the pf2-luc 
plasmid  (Promega) was measured  using a Luminoskan Luminometer (Labsystems) using 
luciferase assay reagent (Promega) as a substrate. The luciferase activity was normalized 
using RSV-βgalactosidase as an internal control by incubating cell lysates in 100 mM 
phosphate buffer (pH 7.0) with ONPG (0.670 mg/ ml), MgCl2 (1 mM), β-mercaptoethanol (45 
mM) at 37°C and determining the absorbance at 420 nm.  
 
11. Immunofluorescence labeling  (I-III) 
Transiently transfected cells were plated  and grown on coverslips  for a minimum of 24 h. 
Cells were washed with PBS, fixed  with 3% parafolmaldehyde (PFA) for 10 minutes at room 
temperature (RT), and  washed 3 times with PBS. Than fixed  cells were permeabilized  for 10 
min in 0.3% Triton X-100 in PBS, and incubated  for 1 h in blocking solution (1% bovine 
serum albumin [BSA] in PBS). Primary antibodies were used  at a 1:500 d iluition in 5% BSA in 
PBS for 1 h at RT. After three washes with PBS, cells were incubated  with secondary 
antibodies, Alexa 488 or 568 (Molecular Probes) at a diluition of 1 : 700 for 1 h  at RT, washed 
and mounted  on slides in Vectashield  containing DAPI (4´, 6´-d iamino-2-phenyilindole, 
Vector laboratories). Cells were analyzed visualized  usin g a Zeiss 510 META laser scanning 
confocal microscope. 
 
12. Detection of apoptosis (I) 
Measurement of apoptosis was detected  by flow cytometry counting of double stained  cells 
for Annexing V-APC and propid ium iodide, collecting both floating and adherent cells. Cells 
grown on a 12 wells plate were washed with PBS, resuspended in 350 µl of annexin V 
binding buffer (2.5 mM HEPES [pH 7.4], 35 mM NaCl, 0.6 mM CaCl2) containing 4 µl/ ml 
human recombinant Annexin V-APC (BD PharMingen) and 5 µg/ ml propid ium iodide 
(Sigma-Aldrich). After 10 min incubation on ice, samples were d irectly analyzed on a 
FACSCalibur flow cytometer (BD PharMingen), by gating GFP-positive cells. 
 
For detection of active caspase-3, cells were washed once in PBS and resuspended in PBS for 
labeling with PE-conjugated  monoclonal active caspase-3 antibody according to 
manufacturer´s instructions. Counting of the number of GFP-positive cells stained for active 
caspase- was performed on a FACSCalibur flow cytometer (BD PharMingen). 
 
13.  Chip assay 
2 X 15 cm2 plates of transfected  HEK293 cells were cross-linked with 1 % formaldehide 
followed by quenching with 125 mM glycine. Pelleted  cells were washed twice in PBS and 
lysed  in SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1 and a protease 
inhibitor cocktail). DNA was fragmented  by sonication with a Bioruptor system (Diagenode), 
samples were d iluited  in immunoprecipitation buffer (20 mM Tris -HCl pH 8.1, 150 mM 
NaCl, 1% Triton-X, protease inhibitor cocktail), than precleared  with protein G-Sepharose 
beads (GE Healthcare) at 4˚C. The IP was performed at 4˚C overnight using c-Jun antibody 
(Cell Signaling), Acetylated  Histone-4 as positive control, normal rabbit serum (IgG) as 
negative control. Immunocomplexes were precipitated  with protein G beads fo r 3 hours at 
4˚C, than washed 3 times in 0.1% SDS, 1% Triton -X, 2mM EDTA, 20 mM Tris-HCl, 150 mM 
NaCl, 3 times in d iffers in 0.1% SDS, 1% Triton -X, 2mM EDTA, 20 mM Tris-HCl, 500 mM 
NaCl N, twice in 20 mM Tris-HCl, 2mM EDTA, 10% Glycerol. Cross-links were reversed  by 
incubation overnight at 65˚C, and than DNA was purified  with phenol-clorophorm and 
ethanol precipitated . The input lanes represent 1% of the material used  for the 
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immunoprecipitation. PCR analysis was performed using Taq polymerase (Fermentas). The 
following primers were used:  
FasL promoter:  
Forward: 5’TGTGTGTGGGGAAGAGATGA3’; 
Reverse: 5’AAATGGCTCTGAGGGGAGAG3’;  
Tnfα promoter:  
Forward: 5’GTCTCCGGGTCAGAATGAAA3’; 
Reverse:  5’CTAGAACTGGGAGGGGCTTC3’. 
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RESULTS AND DISCUSSION  
 
1. Role of AATF in UV-induced stress   
 
1.1 Cloning of AATF 
We decided  to clone the three d ifferent murine isoforms of AATF into EGFP-C1 and EGFP-
N3 vector in order to construct an AATF-EGFP fusion protein in which the fluorescent GFP 
tag would allow an easy visualization of the subcellular localization of AATF. In order to 
maximize the chance of cloning all known AATF isoforms, we  amplified the corresponding 
cDNAs from three different murine tissues, brain, lung and testis described  to express high 
amounts of AATF. AATF1 cDNA was amplified  and cloned from brain tissue, AATF2 cDNA 
from lung and AATF3 from testis. The amplified  AATF cDNAs were cloned into EGFP-C1 
and EGFP-N3 vectors. The generated  plasmids were d igested  with EcoRI and  KpnI to verify 
the insertion of a correct size fragment encoding for AATF 1, 2 and 3 of respectively 1581, 
1374 and 1239 bp (Figure 1A). Plasmids containing the correct size fragments were 
sequenced and transfected  into Cos7 cells to confirm that the fus ion protein AATF-GFP was 
in-frame and correctly expressed . Cell lysates from the AATF isoforms transfected  cells were 
loaded on a gel for western blot analysis with GFP antibody and confirmed the generation of 
a fusion protein AATF1-GFP of approximately 95 kDa (Figure 1B and C). Cells transfected 
with the same AATF constructs were also fixed  and mounted  on a microscopy glass to 
visualize the cellular localization of the generated  fusion protein.  The all three AATF 
isoforms fused  to GFP were able to change the localization of GFP from the cytoplasm to th e 
nucleoli (Figure 1D). 
 
 
 
 
 
 
Figure 1. Cloning of the AATF isoforms 1, 2 and 3 into EGFP vector. (A) Amplified  AATF was 
cloned  into EGFP vector. Plasmid s were screened  by restriction d igestion with EcoRI and  KpnI to 
verify the insertion of a fragment of 1581 bp corresponding to AATF isoform 1 (AATF1), 1374 bp 
corresponding to AATF isoform 2 (AATF2) and  1239 bp corresponding to AATF isoform 3 (AATF3). 
The d igested  plasmids loaded  on an agarose gel show the successful cloning of inserts of the expected  
size. (B, C) The generated  constructs AATF1-GFP, AATF2-GFP and  AATF3-GFP were transfected   into 
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Cos7 cells to verify that the AATF isoforms cDNAs were in-frame with the EGFP coding sequence and  
expressed  as a fused  protein AATF-GFP. Lysates of transfected  cells were loaded  on a gel for western 
blotting against GFP. In B) in order from left to right AATF1-GFP, AATF3-GFP, empty, AATF2-GFP, 
in C) GFP vector, AATF1-GFP, AATF2-GFP. D ) Cos7 cells were transfected  with AATF-GFP or GFP 
vector, fixed , stained  with Dapi to visualize the nucleus and  mounted  on a microscopy glass. Confocal 
microscopy images show a cytoplasmic d istribution of the empty vector GFP and  a nucleolar 
localization for the fusion construct AATF-GFP. 
 
 
1.2  AATF expression level determines sensitivity to UV-induced apoptosis 
To investigate whether AATF expression level could  influence the induction of apoptosis 
upon UV irradiation, we compared  the apoptotic rate of mouse embryonic fibroblasts (MEF) 
or HEK293 cells overexpressing AATF-GFP or GFP empty vector. For all experiments 
described  in this thesis if not stated  otherwise, we used  the full length AATF 1 isoform 
cloned into EGFP-C1 vector as previously described . One day after transfection, cells were 
exposed to UVC radiation (20 µJ for MEFs, 100 µJ for HEK293).  Immediately after irrad iation 
cells were further incubated  in new fresh medium and collected  for analysis at the indicated 
time points. Already after 24 hours,  morphological analysis of cells transfected  with AATF-
GFP  d isplayed a much higher amount of detached and dead cells compared  to cells 
transfected  with the empty GFP vector (I, Fig. 1A), indicating that AATF can in this system 
promote apoptosis. Interestingly, a 2-fold  increase in the amount of dead cells in cells over-
expressing AATF is occurring already in the absence of an apoptotic stimulus and could  for 
example indicate that high level of AATF could  saturate regulatory factor(s)which would 
than  be insufficient to regulate and prevent unwanted  AATF activity.To quantitate these 
results, we performed  FACS counting of the number of transfected  cells stained  for active 
caspase-3 and FACS counting of  the number of transfected  cells double stained  for 
AnnexinV and Propid ium Iodide (PI), both established  markers for apoptosis (I, Figures.1B 
and  1C). Both quantitative analysis confirmed that AATF was able to sensitize cells to 
apoptosis by up to 3-fold  when compared  to cells transfected  with the control vector. The 
higher amount of dying cells within the AATF-GFP population was increasing in a time-
dependent manner and involved caspase-3 activation, as shown both by FACS counting of 
the number of cells labeled  for active caspase-3 (I, Fig. 1B) and by the western blot analysis of 
the respective immuno-lysates blotted  against cleaved and activated  caspase-3 (I, Fig. 1D). In 
the future, it would  be of interest to verify if AATF-mediated  enhancement of apoptosis is 
caspase-dependent, for example by inhibiting caspases activation with a selective inhibitor, 
like z-VAD. This aspect was not addressed in the article and will not be further developed in 
this thesis. 
 
1.3  AATF promotes c-Jun activation upon stress induction 
Considering the well-known involvement of the AP-1 transcription factors in the UV 
response and as apoptosis mediators, we wanted to verify whether the marked increase in 
cell death upon AATF overexpression could  correlate with an increase in the 
phosphorylation and activation of this family of transcription factors. To this end , we 
compared  by western blotting the activation of c-Jun and ATF-2 using antibodies 
recognizing their phosphorylated  and activated  forms, ph-S73-c-Jun and ph-Thr-69/ 71-
ATF2, in cells overexpressing AATF-GFP or GFP empty vector exposed to UV irradiation. 
Cells overexpressing AATF-GFP displayed a more pronounced phosp horylation and 
activation of c-Jun compared  to the control vector but a similar activation potential of the 
other AP-1 family member, ATF-2 (I, Fig. 2A). Moreover, AATF-GFP overexpression was 
able to maintain c-Jun activated  for up to 72 h, whereas in cells overexpressing GFP, c-Jun 
phosphorylation began to decline after 24 hours (I, Fig. 2C). These find ings suggest a 
plausible link between AATF sensitization to UV-mediated  apoptosis and  c-Jun enhanced 
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activation, whose pro-apoptotic function is thought to be associated to its sustained and 
prolonged activation (Hibi, Lin, Smeal, Minden, & Karin, 1993) (Chen, Wang, Templeton, 
Davis, & Tan, 1996). 
 
In parallel, we decreased  the expression levels of AATF by siRNA transfection and found 
that the strength of c-Jun activation was proportional to the levels of AATF protein 
expression. We downregulated  AATF in HEK293 cells using a pool of four d ifferent AATF 
siRNAs and verified  the decrease in AATF expression levels both by western blotting and by 
semi-quantitative RT-PCR (I, Fig. 2 B, D and G).  Cells were then exposed to 100 µJ UV 
radiation and harvested  for analysis at the same time points analyzed  for AATF-GFP 
overexpression experiment. Western blot analysis showed that the blockage of AATF 
expression completely abrogated  activation of c-Jun both at an early stage of the UV-
response and  at later time points (I, Fig. 2B and D), indicating that JNK-mediated 
phosphorylation of c-Jun is dependent and  proportional to AATF expression levels. We next 
analyzed  the activity of a c-Jun construct which has the c-Jun DNA binding domain replaced 
by the DNA binding domain of the yeast transcription factor Gal4 (Gal4-c-Jun), coupled  to a  
luciferase-based  reporter assay. This construct allowed us to focus only on c-Jun 
transactivation capacity and to exclude an effect of AATF in regulating c-Jun affinity to its 
specific DNA cis regulatory elements. Results showed that increasing amounts of AATF-GFP 
were able to promote the transcriptional activity of the Gal4-c-Jun construct in a proportional 
manner but it had  no relevant effect on the induction of the Gal4-dbd (DNA binding 
domain) construct or when AATF-GFP was replaced  by the GFP empty vector (I, Fig. 2E). 
These results showed that AATF is promoting the activation of c-Jun transcriptional 
potential independently from c-Jun capacity to bind  to its DNA responsive elements. 
Different regulatory mechanisms governing c-Jun transcriptional activity have been 
described  in literature. The best known is the phosphorylation of c-Jun N-terminal region by 
the c-Jun N-terminal kinases (JNK) which interestingly seems to be necessary for activating 
the pro-apoptotic function of c-Jun (Ham et al., 1995; Le-Niculescu et al., 1999; Watson et al., 
1998), for allowing the interaction with the RNA helicase RHII/ Gu during a stress response 
(Westermarck et al., 2002) and  for promoting the dissociation of the HDAC3-containing 
repressor complex (Weiss et al., 2003). Of note, both AATF and the RNA helicase RHII/ Gu 
are localized  in the nucleoli and  both increase their nucleoplasmic localization upon a stress 
stimulus (I, Fig. 4D) (Westermarck et al., 2002), suggesting a p lausible cooperative action for 
AATF and RHII/ Gu in the regulation of c-Jun transcriptional activity upon an apoptotic 
insult.  
 
The identification of pro-apoptotic targeted  genes upregulated by AATF in a c-Jun-
dependent manner would  be instrumental in understanding the physiological relevance of 
AATF stimulatory effect on c-Jun activity. The identity of the gene(s) necessary for c-Jun 
mediated  apoptosis is not clear. However, the pro-apoptotic genes Fas-L and  TNF-α  can be 
induced by c-Jun and constitute therefore reasonable candidate apoptosis mediators  (Fan & 
Chambers, 2001).  
 
Hence, we sought to investigate whether AATF was able to modulate the induction of the 
well-known c-Jun target genes, Fas-L and  Tnfα. To this end , we either overexpressed  AATF-
GFP or downregulated  endogenous AATF in HEK293 cells and  exposed cells respectively to 
100 or 140 µJ UV irradiation. After 12 hours, cells were collected for analysis of Fas-L and 
Tnfα mRNA levels by semi-quantitative RT-PCR. Results showed that modulation of AATF 
expression level by overexpression or downregulation by AATF siRNA in UV-irradiated 
cells was directly proportional to the induction  of Fas-L and  TNF-α mRNA levels (I, Fig. 2F-
G). Cells from the same experiment were harvested  after 24 h for western blot analysis using 
Results and Discussion
  
45 
 
an antibody against Fas-L. In cells overexpressing AATF-GFP we observed a robust increase 
in Fas-L protein levels when compared  to cells transfected  with GFP empty vector (Figure 2).  
 
 
 
 
 
 
The fact that depletion of AATF was able to prevent the induction of Fas-L and  Tnfα (I, Fig. 
2G and data not shown), suggests that AATF could  function as a regulator of c-Jun 
transcriptional activity. To verify that AATF-mediated  induction of Fas-L and TNF-α was due 
to an effect on c-Jun transcriptional activity and not on another  transcription factor, we 
compared  the induction of TNF-α in wt MEF and in c-Jun-deficient (c-Jun-KO) MEF cells 
overexpressing AATF-GFP or GFP empty vector (I, Fig. 2H-I). TNF-α  mRNA levels were 
analyzed by semi-quantitative RT-PCR from cells harvested  24 hours after transfection and  
showed that TNF-α mRNA is induced upon AATF overexpression only in wt MEFs and not 
in c-Jun-KO MEF cells. Moreover, the reintroduction of c-Jun in c-Jun-KO MEFs restored the 
expression of TNF-α only when AATF was coexpressed  with c-Jun (I, Fig. 2H). Together, 
these results provide further evidence that AATF promotes c-Jun-mediated  induction of the 
pro-apoptotic genes Fas-L and  Tnfα and is in line with our findings showing an increased  cell 
death rate in cells overexpressing AATF (I, Fig.1). Finally, we examined whether AATF was 
able to promote the binding of c-Jun to the Fas-L and Tnfα gene promoter. To this end , we 
performed chromatin immunoprecipitation of endogenous c-Jun from UV treated  HEK293 
cells transfected  with AATF-GFP or GFP. As a positive control for transcriptionally active 
chromatin region, we used  antibodies against acetylated  Histone 4 (Ac-H4) and as a negative 
control rabbit IgG (IgG) (Figure 3). ChIP assays revealed  an increased  association of c-Jun to 
the FasL and  Tnfα gene promoter when AATF was overexpressed , suggesting that AATF 
may promote c-Jun recruitment to target gene promoters. 
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In summary, these findings identify AATF as a novel regulator of the proapoptotic functions 
of c-Jun. It would  be of interest in the future to further investigate and  pinpoint the pathway 
leading from AATF-c-Jun activation to apoptosis. For example by inhibiting Fas-L or TNF-α 
with a specific blocking antibody or by using Fas-L or TNF-α deficient cells, it could be 
possible to d iscriminate whether AATF-induced  apoptosis is relying on Fas or on TNF-α 
mediated  signaling. Also, considering the multiple processes activated  by TNF-α and Fas-L, 
it would be of interest to investigate a possible involvement of AATF in regulating other 
processes promoted  by Fas-L and TNFα , such as proliferation and d ifferentiation  of some 
cell types (reviewed in Aggarwal, 2003; Schuetze et al., 2008 and in the Review of literature 
section).  
 
1.4. AATF promotes cell death in a c-Jun-dependent context 
A clear link between AATF-mediated  c-Jun activation and apoptosis came with the use of c-
Jun-deficient (KO) MEF cells. As cells lacking c-Jun were impaired  in AATF-mediated 
induction of Fas-L and  TNF-α (I, Fig. 2 H-I), we investigated  whether c-Jun deficient cells 
were also impaired  in the AATF-mediated  sensitization to UV-induced apoptosis. We 
reasoned that if AATF was promoting apoptosis by stimulating c-Jun-mediated  induction of 
the pro-apoptotic genes Fas-L and  TNF-α, than in a c-Jun deficient context, AATF would  lose 
its capacity to enhance apoptosis. To test this hypothesis, we overexpressed  AATF-GFP or 
GFP empty vector in w ild-type or c-Jun-KO MEF cells and  the following day we exposed 
cells to 15 µJ UV irradiation. Irradiated  and untreated  cells were collected after 48 hours for 
assessment of cell death. FACS analysis of the number of cells stained  for AnnexinV and PI 
showed a marked increase of dead  cells only when AATF-GFP was overexpressed  in w ild-
type MEF cells and  not in c-Jun-KO cells (I, Fig. 3). The number of dying cells was three 
times higher when AATF-GFP was expressed  in wild-type cells than in c-Jun-deficient cells. 
These results provide evidence that the pro-apoptotic effect of AATF is dependent on the 
presence of c-Jun and further suggest that it could  be mediated  by the previously described 
increase in expression of pro-apoptotic-c-Jun target genes, such as Fas-L and  TNF-α (I, Fig. 2 
F-I).  
 
1.5. Endogenous AATF interacts and co-localizes with c-Jun during the UV 
response  
As AATF was able to promote apoptosis in a c-Jun-dependent manner, we sought to 
determine whether AATF was able to interact with c-Jun. To this end , we performed 
immunoprecipitation analysis of endogenous c-Jun or endogenous AATF from HEK293 cells 
UV-irradiated  and harvested  at d ifferent time points. Western blots against endogenous 
AATF or endogenous c-Jun respectively, showed an induced but transient interaction 
between c-Jun and AATF at an early phase of the UV response (I, Fig. 4 A and B). The 
interaction was more pronounced at an early stage, and  decreased  during the time course 
analyzed . Interestingly, the interaction seemed to precede the increase in phosphorylated  c-
Jun, indicating that AATF might determine the amount of c-Jun which can be 
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phosphorylated  by JNKs, for example by promoting the release of c-Jun inhibitory complex 
or by ferrying key scaffold ing or regulatory factors to the c-Jun complex.  
 
In parallel, we investigated  whether AATF change localization upon UV exposure. Confocal 
microscopy images of cells stained  for endogenous AATF and nucleolin at different times 
points of the UV response, indicated  that AATF is a nucleolar -localized  protein in the 
absence of stress stimuli (I, Fig. 4D). After UV irradiation, the localization of AATF becomes 
increasingly nucleoplasmic and, in most cells, showed a complete loss of nucleolar 
localization after four hours of UV treatment (I, Fig. 4D). Interestingly, the increase in 
nucleoplasmic AATF upon UV-irradiation corresponded to an increase in colocalization with 
c-Jun that remained diffusely nucleoplasmic throughout the time course (I, Fig. 4E). 
Together, these results indicate that the asymmetric subcellular d istribution of AATF and c-
Jun might serve as a constraint to avoid  unwanted  or deregulated activation of c-Jun by 
AATF interaction. Similarly, several regulators such as MDM-2 and VHL (Mekhail et al., 
2004; Sherr, 2006) are sequestrated  in the nucleolus under normal growth conditions and are 
released  upon stimulus to allow for interaction with their nuclear target protein s (Olson, 
Dundr, & Szebeni, 2000; Pederson & Tsai, 2009). The absence of a membranous border and 
the central localization within the nuclear space, render the shuttling of proteins from and to 
the nucleolus not only rapid , but also affordable in terms of ATP consumption (Stark & 
Taliansky, 2009). Interestingly, the interaction between endogenous AATF and endogenous 
c-Jun upon irradiation is transient, occurs at an early stage of the UV response and is lost at 
the latest time point analyzed (4 hours) (I, Fig. 4A and B). Instead , endogenous AATF retains 
a nucleoplasmic localization also 4 hours after UV irradiation, when the interaction with c-
Jun is lost and  even though both AATF and c-Jun are localized  in the nucleus (I, Fig. 4D and 
E). These findings suggest the presence of additional regulatory mechanism(s) to adjust the 
amount and duration of AATF and c-Jun association in the nucleus, and  thereby set a 
controlled c-Jun transcriptional activation and consequent gene expression profile.  
 
1.6. Characterization of AATF functional domains 
We next generated  AATF deletion mutants to map the domains of AATF mediating the 
interaction with c-Jun. To this end , we generated  two mutants harboring C-terminal 
truncations, one encoding exons I-X, AATF-GFP(1-454) and one encoding exons I-IV, AATF-
GFP(1-198), and  one mutant harboring a N-terminal truncation encoding exons V-XIII, 
AATF-GFP(199-526). In addition, we made use of an AATF isoform cloned from muscle 
cDNA, AATF-GFP(Δ125-246), which lacks exons IV-V (Figure 4). We transfected  HEK293 
cells with our AATF-GFP mutants and  performed immunoprecipitation analyses of 
endogenous c-Jun to identify the domains of AATF required  for bindin g to c-Jun. Blotting 
with an anti-GFP antibody the c-Jun immunoprecipitates from   transfected  cells , showed 
that AATF-GFP(1-454) and AATF-GFP(199-526) were able to associate with endogenous c-
Jun, while AATF-GFP(1-198) failed  to bind  to c-Jun (I, Fig. 5A). These results indicate that 
AATF amino acids 199-454 are necessary to allow the interaction with c-Jun.   
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Figure 4. Schematic representation of the generated AATF deletion mutants. For each AATF 
mutant the encoding exons and  the corresponding tran slated  amino acid s are shown  
 
 
We next tested  the capacity of the AATF deletion mutants to stimulate an AP-1-responsive 
luciferase reporter plasmid . While expression of w ild-type AATF led  to a robust increase in 
AP-1 activity, both our C-terminal truncation mutants, AATF-GFP(1-454) and AATF-GFP(1-
198) were unable to stimulate AP-1 activity. In contrast, the N -terminal truncated mutant 
AATF-GFP(199-526) and also the AATF-GFP(Δ125-246) promoted  c-Jun activity at levels 
comparable or higher than the full-length AATF-GFP(1-526) (I, Fig, 5B). Taken together, 
these results indicate that the C-terminal tail of AATF, encompassing amino acids 455-526, is 
necessary for stimulation of  the AP-1 activity. 
 
The identification of amino acids 455-526 of AATF as the region necessary to enhance c-Jun 
activity, prompted  us to investigate whether the d ifferent capacity to stimulate AP-1 activity 
was d irectly proportional to the capacity to promote apoptosis. For this purpose, we 
overexpressed  the AATF-GFP deletion mutants in MEF cells and  determined the degree of 
apoptosis by FACS counting of cells double stained  for PI and AnnexinV. In accordance with 
the previous AP-1 reporter results, cells transfected  with  AATF-GFP(199-526) and AATF-
GFP(Δ125-246) deletion mutants, that stimulated AP-1 promoter activity, d isplayed a high 
number of dead  AnnexinV-positive cells, whereas cells transfected  with the C-terminal 
truncated  deletion mutants AATF-GFP(1-454) and AATF-GFP(1-198), that d id  not stimulate 
AP-1 activity, were also defective in promoting apoptosis  as shown by the lower number of 
AnnexinV-positive cells (I, Fig. 5C). However, the pro-apototic effect of the AATF mutants 
could  also be mediated  by other factors than c-Jun. To exclude this possibility, we decided  to 
test the capacity of the AATF mutants to induce apoptosis in c-Jun-deficient MEF cells (c-Jun-
KO MEFs), reasoning that if the AATF mutants were regulating the activity of some other 
apoptotic factors than c-Jun, we would  detect a similar cell death rate in wild  type and c-Jun-
KO MEFs. To this end, we overexpressed  AATF mutants in c-Jun-KO MEFs and , the 
following day, we harvested  both floating and adherent cells for FACS analysis of dead  cells. 
FACS counting of AnnexinV positive cells and  western blot analysis for caspase -3 cleavage 
showed that in a c-Jun-deficient background, all the AATF mutants were unable to promote 
apoptosis, providing strong evidence for the interplay between AATF and c-Jun and for 
placing c-Jun as a downstream target of AATF (I, Fig. 5C and data not shown).   
 
Results and Discussion
  
49 
 
These results indicate that the ability of AATF to sensitize cells to apoptosis is dependent on 
its capacity to activate c-Jun transcriptional activity. Together, our results demonstrate that 
AATF amino acids 199-453 mediate binding to c-Jun while AATF amino acids 455-526 are 
necessary for stimulating the AP-1 activity and for promoting apoptosis in a c-Jun dependent 
context.  
 
To further characterize the AATF deletion mutants we analyzed the subcellular localization 
of the mutants in HEK293 and MEF cells. We performed analysis of confocal microscopy 
images of cells transfected  with AATF deletion mutants and  stained  for DAPI to visualize the 
nucleus, nucleolin to visualize the nucleoli or actin to visualize the cell morphology. 
Confocal images of cells transfected with AATF-GFP mutants showed that the N-terminal 
deletion mutant AATF-GFP(199-526) had a nucleolar localization similar to the nucleolar 
d istribution of the full length AATF-GFP(1-526), whereas the C-terminal truncated  isoform, 
AATF-GFP(1-454) showed a nucleoplasmic d istribution  and was excluded from the nucleoli 
(I, Suppl. Figure X). These results suggest that AATF C-terminal tail (AATF amino acids 455-
526) is important to target AATF to the nucleoli. Interestingly, AATF exon XI, encoding for 
amino acids 455-482, contains a series of basic amino acids, such as the repetition of lysine 
residues which are typical for nucleolar targeting  sequences (Birbach, Bailey, Ghosh, & 
Schmid, 2004; Reed et al., 2006).  
To identify the region of AATF required for the nucleolar and  nuclear targeting, we 
generated  the following GFP-tagged  constructs: AATF(1-350)-GFP encoding the first 7 exons 
of AATF and containing a putative nuclear targeting sequence (Passananti et al., 2007) and 
AATF(455-484)-GFP encoding AATF exons XI and containing a putative nucleolar targeting 
sequence (Figure 5). Confocal microscopy images of MEFs transfected  with the deletion 
mutants revealed  that while AATF(1-198)-GFP had an exclusively cytoplasmic distribution, 
AATF(1-350) showed an evident nuclear localization, indicating that the putative nuclear 
localization signal translated  by exon VII (amino acid  290-310) is functional and  sufficient to 
target AATF to the nucleus. Cells transfected with AATF(1-454)-GFP which lacks the 
potential nucleolar targeting sequence encoded by exon XI, d isplay a nuclear but not 
nucleolar d istribution. Instead , cells transfected  with the construct AATF-GFP(455-482) 
showed that the fusion of AATF exon XI to GFP is sufficient to target GFP to the nucleoli and  
that AATF amino acids 455-482 contain a functional nuclear and  nucleolar targeting 
sequence (Figure 5). It is tempting to speculate that d ifferent AATF isoforms could  have 
d istinct effects on c-Jun activity, provid ing a wide range of tissue-specific modes of c-Jun 
regulation. The characterization and identification of their tissue-specific conditions of 
expression will be of importance for cancer research. 
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Figure 5. Identification of nuclear and nucleolar targeting sequence on AATF. MEFs  were 
transfected  with d ifferent AATF deletion mutants. The following d ay cells were fixed  and  stained  
with DAPI to visualize the nucleus, and  actin to visualize the cell morphology or  nucleolin to identify 
the nucleoli. AATF(1-526)-GFP which encodes the full length AATF isoform 1, shows a typical 
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nucleolar localization, AATF(1-198)-GFP has a exclusive cytop lasmic d istribution while AATF(1-350)-
GFP shows a nuclear localization, ind icating the presence of a functional nuclear targeting signal. 
AATF(455-484)-GFP d isplays a nucleolar and  nuclear localization identifying the region of AATF 
mediating nucleolar targeting. 
 
 
 
Together, our results identify AATF as a novel regulator of the transcription factor c-Jun and 
reveal that AATF expression levels can determine the magnitude of phosphorylation and 
transcriptional activation of c-Jun upon several stress stimuli. AATF loses its nucleolar 
localization upon UV irradiation and transiently interacts with c-Jun in the nucleoplasm 
(Figure 6). Based  on our analyses, amino acids 265-454 of AATF are required  for the 
interaction with c-Jun while amino acids 455-482 of AATF are necessary to target AATF to 
the nucleoli. Moreover, amino acids 455-526 of AATF are also required to enhance c-Jun 
transcriptional activity and promote apoptosis in a c-Jun-dependent context, possibly 
through the induction of the proapoptotic genes Fas-L and  Tnfa, whose products and  
activated  signaling pathways could  function as a likely mechanism of amplification of the 
apoptotic response. 
 
 
 
 
 
 
 
 
Figure 6. AATF regulates c-Jun activity. (A) Under physiological conditions AATF is retained  in 
the nucleolus through a nucleolus targeting signal located  in amino acids 455-484. (B) Upon UV 
irrad iation AATF translocates into the nucleus where it interacts with c-Jun through AATF amino 
acids 199-454. (C) JNK can bind  and  phosphorylate c-Jun while AATF is released  from c-Jun.  
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2. AATF activates c-Jun transcriptional activity in a JNK-independent 
manner 
 
Activation of c-Jun has been classically attributed to JNK-mediated  phosphorylation of c-Jun 
on residues Ser63 and Ser73 (Smeal et al., 1991; Smeal et al., 1992; Pulverer et al., 1991). The 
correlation between AATF expression levels and  c-Jun phosphorylation status and 
transcriptional activation, prompted  us to study whether AATF would  stimulate c-Jun 
activity by enhancing the JNK kinases activities. 
 
2.1 JNK activation is not affected by AATF expression levels  
UV exposure promotes a rapid  and strong activation of the JNK family, which results in the 
phosphorylation of c-Jun (Hibi et al., 1993). To investigate whether AATF was affecting the 
activation of the JNK pathway, we analyzed the activation of JNKs in UV-irradiated  cells by 
western blotting, using a phospho-specific antibody recognizing phosphorylated  and 
activated JNKs on residues Thr 183 /  Tyr185. Blots showed that upon UV exposure 
overexpression of AATF enhanced the phosphorylation of c-Jun when compared  to cells 
transfected  with the GFP control vector, but d id not significantly affect the phosphorylation 
status of JNKs (II, Fig.1), suggesting  that AATF does not have a d irect effect on JNK 
activation but rather acts downstream of it. 
 
2.2. AATF regulates c-Jun activity in a JNK-independent manner 
As AATF enhanced c-Jun phosphorylation without increasing the JNK activation, we 
determined if c-Jun phosphorylation could  be mediated  by another kinase or if AATF might 
promote c-Jun phosphorylation by another mechanism, for example by relieving the c-Jun 
associated inhibitory complex. To this end , we performed an UV-irradiation experiment with 
cells overexpressing AATF-GFP in presence of the JNK inhibitor SP-600125. We reasoned 
that if other kinases were involved in enhancing the phosphorylation status of the c-Jun N-
terminal tail, the treatment with JNK inhibitor should  not significantly influence c-Jun 
phosphorylation status upon UV exposure of AATF transfected  cells. However, SP-600125 
treatment was able to block AATF-mediated  c-Jun phosphorylation, suggesting that the 
JNKs are the responsible kinases for AATF-promoted  phosphorylation of c-Jun (II, Figure 
2A).  
 
Phosphorylation of c-Jun is associated  with transcriptional activation and at least some 
functions of c-Jun seem to be dependent on its phosphorylation status, such as the capacity 
to induce apoptosis (Watson et al., 1998). We explored  whether inhibition of c-Jun 
phosphorylation by SP-600125 treatment also inhibited  AATF-mediated enhancement of c-
Jun transcriptional activity. To this end , w e made use of the previoulsy described  c-Jun 
construct which has the c-Jun DNA binding domain replaced  by the DNA binding domain of 
the yeast transcription factor Gal4 (Gal4-c-Jun), coupled  to a luciferase-based  reporter assay. 
This construct allow ed us to study c-Jun transactivation capacity independently of the c-Jun 
DNA binding domain. We expressed  the Gal4-c-Jun construct together with β-Gal, the 
luciferase reporter (pf-2-Luc), GFP or AATF-GFP, and analyzed the ratio of luciferase versus 
β-galactosidase activities. Surprisingly, the activity of the Gal4-c-Jun construct was 
unaffected  by the inhibition of JNK activity  when AATF-GFP was overexpressed , suggesting 
that JNK activity and phosphorylation is not required  for AATF-mediated  stimulation of the 
Gal4-c-Jun transcriptional activation  (II, Fig. 2B). These results prompted  us to investigate 
whether c-Jun phosphorylation was required  for AATF to stimulate c-Jun transcriptional 
activity. To this end  we made use of either a Gal4-c-Jun mutant construct defective in 
binding to JNK (Gal4-c-JunΔ) or of a Gal4-c-Jun mutant construct in which the JNK phospho 
target sites were replaced  by alanine residues (Gal4-c-JunAA). Surprisingly, increasing 
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amounts of AATF-GFP were able to stimulate the transcriptional activities of both c-Jun 
phosphorylation-deficient constructs, Gal4-c-JunΔ and Gal4-c-JunAA, with a similar 
magnitude to the wild  type Gal4-c-Jun construct (II, Fig.3C). These findings suggest that 
AATF stimulates c-Jun transcriptional activity independently of JNK-mediated 
phosphorylation of the c-Jun target sites Ser63/ 73. 
 
 
 
2.3 HDAC1 promotes association of AATF to c-Jun 
Phosphorylation-independent activation of c-Jun is poorly characterized . It is known that 
some functions of c-Jun do not require phosphorylation of residues 63/ 73. Indeed, unlike c-
jun-deficient mice which d ie in utero, knock-in mice, expressing only a non-phosphorylable c-
Jun S63/ 73A mutant (c-Jun-A63/ 73) are viable and develop normally (Hilberg, Aguzzi, 
Howells, & Wagner, 1993). Also MEFs derived  from the c-Jun S63/ 73A mouse model grow 
poorly in culture and suggests that some functions of c-Jun do not require S63/ 73 
phosphorylation (Wisdom, Johnson, & Moore, 1999). Weiss and coworkers provided results 
showing that JNK phosphorylation allows for the release of an inhibitory complex which 
normally keeps c-Jun inactive. They also showed that c-Jun inhibitory complex can be 
released  by titrating the repressor by co-expression of a competitor such as c-Jun itself. In this 
case overexpressed  c-Jun acts as a binding competitor for the inhibitor complex, thereby 
reliving the repressed  state and, increasing c-Jun transcriptional activity in absence of JNK 
activity. While the regulation and composition of the c-Jun repressing complex remains to be 
determined , Weiss and coworkers have shown that HDAC proteins are important members 
of the inhibitory complex. Both HDAC1 and 3 can associate with c-Jun and associated 
HDAC3 keeps c-Jun transcriptional activity inhibited .   
 
The above decribed  findings prompted  us to investigate whether AATF affected  the 
association of the HDAC-containing inhibitory complex with c-Jun. For this purpose, we first 
performed immunoprecipitation analysis of cells overexpressing AATF-GFP and HDAC1-
Flag or HDAC3-Flag and found that AATF associated  with both HDAC1 and HDAC3 and 
endogenous c-Jun (II, Fig. 3A, unpublished  data). Next, we sought to investigate whether 
AATF was able to affect the association of HDAC to c-Jun. Interestingly, overexpression of 
HDAC1 increased the association of AATF to endogenous c-Jun, suggesting that HDAC 
proteins might play an important role in determining the amount of AATF associated  to c-
Jun and thereby AATF-mediated  regulation of c-Jun transcriptional activity (II, Fig. 3B). 
These results prompted  us to explore whether HDAC could  regulate AATF subcellular 
localization. Indeed, confocal microscopy analysis of HEK293 cells transfected  with AATF-
GFP and HDAC1 or 3 showed that both HDAC1 and 3 overexpression promote the shuttling 
of AATF or its stabilization in the nucleoplasm (II, Fig. 4). These results indicate that HDACs 
mediate the release of AATF from the nucleoli into the nucleus thereby increasing AA TF 
interaction with c-Jun. Presumably, AATF nucleolar retention might be important to avoid 
unwanted  c-Jun activation and could  function as a tool to limit the duration and magnitude 
of c-Jun transcriptional activation. Future experiments will be d irected  towards 
understanding the precise nature of the regulation of c-Jun through AATF and HDAC-
containing complexes. For example, it is not yet known whether the HDAC-mediated 
increase of AATF in the nucleoplasm, in the absence of any additional stress signals and/ or 
JNK phosphorylation, is sufficient to activate c-Jun transcriptional activity. Also, it will be of 
interest to explore whether the deacetylase activity of HDAC is necessary to enable the 
AATF release from the nucleolus. Indeed, acetylation can modify the structure of the protein 
and allows for selective and specific interactions with other factors that can in turn dictate for 
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example the retention in one compartment or the association to a specific cellular structure 
(reviewed in Glozak et al., 2005; Yang & Seto, 2007).  
 
 
 
3. Protein kinase C ξ  induces myoblast differentiation by targeting 
Cdk5/p25 
 
Cell d ifferentiation is a complex and multistep process which drives a proliferative single cell 
to exit the cell cycle and to engage into a tissue-specific and  irreversible program of 
specialization which transforms a multipotent cell into a determined cell type. This process 
involves a myriad  of interconnected  pathways which need  to be spatially and sequentially 
orchestrated  to allow a complete rearrangement of the cell localization, morphology, 
recognition of fusion  partner cell, and  expression of tissue function -specific components 
(reviewed in Le Grand & Rudnicki, 2007).  Our and other research groups have identified 
and described  an essential role for the Cdk5/ p35 signaling complex in the d ifferentiation of 
both neuronal and  muscle progenitor cells. This last PhD project further develops and 
caractherizes the role of the Cdk5/ p35 complex in muscle differentiation and identifies in the 
atypical PKCξ , the upstream regulator. 
 
3.1. Protein kinase Cξ  activity is necessary for myoblast differentiation  
The acquisition of a definitive protein expression repertoire and function, and  hence of a cell 
type identity during differentiation, requires the inhibition and  activation of several d istinct 
pathways which allow for a complete change in cell morphology and phenotype.  
Among the d ifferent pathways involved, we have focused  on deciphering the roles of the 
atypical PKCξ , in regulating myoblast d ifferentiation. Several studies have shown that PKCξ  
kinase activity is required  for the proliferation, migration and differentiation of progenitor 
cells of d ifferent cellular lineages, but the downstream targets of PKCξ  regulating these 
processes remain unclear (Calcerrada et al., 2002; White et al., 2002; Wooten et al., 1997). To 
assess the necessity of PKCξ  activity also in the muscle d ifferentiation model, we either 
downregulated PKCξ  expression by siRNA (III, Fig. 1A) or blocked the kinase activity by 
treatment with a myristoylated  pseudosubstrate peptide (PS) in myoblasts induced to 
d ifferentiate (III, Fig. 1B). Confocal microscopy analysis of primary myoblasts  showed a 
marked reduction in the number of myotubes and of cells stained  for myosin heavy chain 
(MHC), a well-known marker for muscle d ifferentiation, in cells transfected  with siPKCξ  or 
treated  with the PKCξ  inhibitor PS, when compared  to the control conditions. Indeed , 
inhibition of PKCξ  completely prevented  the fusion of primary myoblasts and  the formation 
of multinucleated  myotubes typical of muscle d ifferentiation. Western blot analysis of 
similarly performed experiments showed that the blockage of PKCξ  activity hindered  the 
expression of muscle d ifferentiation markers, such as MHC, desmin and troponin (III, Fig. 2 
and data not shown). Importantly, we performed similar d ifferentiation experiments using 
CalphostinC, an inhibitor of nPKC and cPKC isoforms, and  our results showed that 
inhibition of nPKC and cPKC had no effect on the d ifferentiation process (III, Suppl. Fig. 1C), 
allowing us to focus on the involvement of the atypical isoform PKCξ . 
These findings suggested  an important role for PKCξ  in regulating the fusion and 
d ifferentiation of muscle progenitor cells. 
 
3.2. Protein kinase Cξ  activity increases during myoblast differentiation 
As the depletion of PKCξ  completely prevented  the fusion of myoblasts and  the  expression 
of typical d ifferentiation markers (III, Fig. 1 and 2), we investigated the levels of protein 
expression and of kinase activity of PKCξ  during myoblast d ifferentiation. To this end, 
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proliferating myoblasts were induced to d ifferentiate by shifting to a differentiation medium 
and harvested  at d istinct time points. In primary myoblasts and  C2C12 cells, western blot 
analysis showed that PKCξ  protein levels remained constant during the analyzed 72 hours 
of d ifferentiation (III, Fig 3A). In contrast, the kinase activity of PKCξ  immunoprecipitated 
from differentiating myoblasts and  analyzed using Histone1 as a substrate, showed that 
PKCξ  kinase activity increases during the d ifferentiation process and reaches a peak after 48 
hours of induction (III, Fig. 3B). This finding indicates that PKCξ  activity is upregulated 
during myoblast d ifferentiation and that its kinase activity might therefore have an 
important role in regulating this process.  
 
3.3 Protein kinase Cξ  regulates Cdk5 activity during myoblast 
differentiation 
Our and other previous studies have identified  the Cdk5/ p35 signaling complex as an 
essential regulator of neuronal and  muscle cell cycle arrest and  d ifferentiation (Cicero & 
Herrup, 2005) (Lazaro et al., 1997; Philpott, Porro, Kirschner, & Tsai, 1997; Sahlgren et al., 
2003). We previously showed that Cdk5 activity is necessary for myoblast d ifferentiation and 
for phosphorylation of the intermediate filament nestin on threonine 316. Cdk5-mediated 
phosphorylation enables the disassembly of nestin filaments which precedes and allows the 
cytoskeletal rearrangements necessary for cell migration and fusion into myotubes (Sahlgren 
et al., 2003). Interestingly, Cdk5 activity is induced during muscle d ifferentiation and peaks 
at 48 hours with similar kinetics as PKCξ  as previously described  (Lazaro et al., 1997). Hence 
we decided  to explore whether Cdk5 and PKCξ  were interacting and regulating each other 
during myoblast d ifferentiation and , if so, which of the two kinases was the upstream 
regulator. For this purpose, we analyzed kinase activities of PKCξ  or Cdk5 in the presence of 
a Cdk5 inhibitor or of a PKCξ  inhibitor respectively by immunoprecipitation of the kinases 
from myoblasts induced to d ifferentiate. Kinase activity assays of immunoprecip itated  Cdk5, 
using Histone 1 as a substrate, showed that inhibition of PKCξ  activity prevented  the 
induction of Cdk5 activity during myoblast d ifferentiation (III, Fig. 4A). On the contrary, 
kinase activity of PKCξ  immunoprecipitated  from differentiating m yoblasts showed an 
induction during d ifferentiation also in the presence of the Cdk5 inhibitor Roscovitine. (III, 
Suppl. Fig. 2A). In fact, kinase assays using Histone 1 as substrate showed that 
immunoprecipitated  PKCξ  from differentiating myoblasts treated with the Cdk5 inhibitor 
Roscovitine had  a similar phosphorylation activity when compared  to PKCξ  
immunoprecipitated  from non-treated  myoblasts. Overall, these results strongly suggest that 
during myoblast d ifferentiation  PKCξ  activity regulates the indu ction of Cdk5 and that, 
therefore, PKCξ  is the upstream regulator of Cdk5 at least in the myoblast d ifferentiation 
system. Accordingly, inhibition of PKCξ  activity by treatment with the PKCξ  inhibitor PS 
during myogenesis had an impact also on downstream Cdk5-regulated  events. Indeed 
confocal microscopy images of d ifferentiating myoblasts stained  with nestin showed that 
inhibition of PKCξ  impaired  the reorganization of nestin filaments into long polymerized 
parallel fibers, which our previous work had shown to be mediated  by Cdk5 
phosphorylation (III, Fig. 4B). Western blot analysis of the correspond ing lysates showed also 
that nestin expression and turnover was compromised  and reduced by PKCξ  inhibition or 
downregulation by siRNA (III, Fig. 4B and C). Overall, our results indicate that PKCξ  
functions as an upstream regulator of Cdk5 activity during muscle differentiation and show 
that PKCξ  activity is necessary to allow cytoskeletal rearrangements leading muscle cell 
morphological changes that are regulated at least partially by Cdk5. 
 
3.4. Cdk5 regulator, p35, interacts with and is phosphorylated by PKCξ  
Cdk5 activity is completely dependent on the association with one of two activation 
subunits, p35 or p39 (Lew & Wang, 1995). p35 levels are regulated  by proteasomal 
Results and Discussion
  
56 
 
degradation (Patrick et al., 1998; Saito et al., 1998), similarly to the regulation of cyclins in 
proliferating cells. However, the molecular mechanisms involved in the synthesis and 
degradation of p35 remain to be elucidated .  The association of p35 to Cdk5 and the cleavage 
of p35 into the more active fragment p25are the key events which trigger Cdk5 activity. 
Therefore, we decided  to explore whether PKCξ  was targeting and regulating the Cdk5 
activator p35 during myoblasts differentiation. First we sought to investigate whether p35 
and PKCξ  can interact with each other. To this end , we immunoprecipitated  p35 or PKCξ  
from Cos7 overexpressing p35 and PKCξ  and blotted  against PKCξ  or p35 , respectively. In 
both cases, the blots showed that p35 and PKCξ  are binding proteins (III, Fig. 5A). Next, we 
explored  whether endogenous p35 and PKCξ  are interacting in differentiating myoblasts. 
PKCξ  was immunoprecipitated  by p35 in differentiating C2C12 and importantly, this 
association was specific for d ifferentiating myoblasts while in proliferating myoblasts the 
interaction was minimal (III, Fig. 5B). The fact that p35 and PKCξ  associate during 
differentiation prompted  us to verify whether p35 could  be phosphorylated  by PKCξ . To this 
end , we performed in vitro PKCξ  kinase assays using as substrate recombinant p35 peptides 
corresponding to p35 amino acids 1-120 and p35 amino acids 208-307.  Results showed that 
only p35 N-terminal domain p35(1-120), which contain the fragment removed upon 
cleavage, is phosphorylated  by PKCξ , while p35(208-307) is not a target of PKCξ  (III, Fig. 5 
D). Next, mass spectrometric analysis of the in vitro phosphorylated  p35 identified  Ser33 as 
one of the main p35 target sites of PKCξ  (III, Suppl. Fig. 4). The identification of this novel 
p35 phospho-site prompted  us to generate a mutated  p35 construct in which Ser33 was 
mutated  to alanine in order to characterize the function of this phosphorylation site during 
d ifferentiation.  
 
3.5. PKCξ  activity regulates calpain-mediated cleavage of p35 during 
myoblasts differentiation 
As the activity of both Cdk5 and PKCξ  increases with similar kinetics during myoblast 
d ifferentiation and reaches peak levels after 48 h, we hypothesized  that an increase in p35 
cleavage could  explain the described  enhanced activity of Cdk5. We therefore examined the 
expression levels of p35 and p25 in differentiating myoblasts in the presence or absence of 
the PKCξ  inhibitor PS. Western blot analysis of d ifferentiating myoblasts showed that p35 is 
cleaved into the more active fragment p25 during d ifferentiation  but this cleavage is blocked 
when PKCξ  is inhibited or downregulated by siRNA (III, Fig. 6A and C). These findings 
indicate that PKCξ  is involved in promoting the cleavage and activation of p35 during 
myoblast d ifferentiation. The proteolytic processing of p35 is mediated  by calpains 
(Kusakawa et al., 2000), calcium-activated  proteases whose activity has been reported  to be 
involved in cell death and in muscle d ifferentiation (Balcerzak et al., 1995; Liang et al., 2006). 
During myogenesis calpains cleave cytoskeletal proteins including vimentin, desmin, talin 
and fibronectin which regulate cell morphology, migration (Leloup, Daury, Mazères, Cottin, 
& Brustis, 2007) and fusion (Dourdin et al., 1997; Honda, Masui, Kanzawa, Tsuchiya, & 
Toyo-oka, 2008; Liang et al., 2006). Calpains do not use specific consensus target sequences 
for cleavage but they generally recognize motifs between conformational domains. In the 
case of p35, calpains recognize and cleave the linker connecting the N -terminal binding 
region and C-terminal p35 globular activation domain (Tarricone et al., 2001). In our study, 
we confirmed that the p25 fragment generated  during myoblast d ifferentiation was mediated 
by calpains as treatment of d ifferentiating myoblasts with calpain inhibitor (Calpain 
Inhibitor III) was able to reduce p35 cleavage induced by d ifferentiation (III, Fig. 6B). Also 
calpains are activated  by autocleavage of their regulatory domain and the identification of a 
cleaved fragment of 75 kDa, corresponding to the catalytic domain, is used  as a marker of 
calpain activation. Surprisingly, we found that inhibition of PKCξ  activity by PS treatment or 
by downregulation of PKCξ  expression by siRNA reduced the cleavage and activation of 
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both the ubiquitous calpain-1 and the muscle-specific calpain-3 (III, Fig. 7 A and B), 
suggesting that PKCξ  activity regulates the activation of calpains during d ifferentiation. 
These findings prompted  us to investigate whether PKCξ  is regulating the activity of 
calpains by d irect interaction and phosphorylation . Immunoprecipitation analysis of 
endogenous PKCξ  and calpain -3 showed that indeed PKCξ  and calpain -3 are interacting 
proteins in myoblasts (III, Suppl. Fig. 7C). Moreover, kinase assays showed that recombinant 
PKCξ  phosphorylates both immunoprecipitated calpain-1 (III, Fig. 7C) and calpain-3 (III, 
Suppl. Fig. 7B), indicating a promoting role for PKCξ  in the regulation of calpain activation 
by interaction and phosphorylation. To substantiate these results  showing a role for PKCξ  in 
regulating calpain activities, we identified another substrate of calpains, RhoA (Kulkarni et 
al., 2002; Castellani et al., 2006), whose cleavage during d ifferentiation was also blocked by 
PKCξ  inhibition (III, Suppl. Fig. 7D). These results indicate that PKCξ  fun ctions as a 
regulator of calpain activation during myoblast d ifferentiation. Considering that PKCα and 
δ , but not PKCξ , are regulated  by calpains, it is tempting to speculate that calpain and PKC 
activities are propelled  by a feed -forward  mechanism (Hong et al., 1995; Liang et al., 2006). 
Therefore, PKCξ  could  function as an upstream regulator of calpains which in turn cleave 
and activate the PKCα and δ  isoforms, further amplifying the signal and downstream 
activated pathways 
 
3.6. PKCξ -mediated phosphorylation of p35 promotes calpain-mediated 
cleavage 
Finally, we wanted  to test whether the identified  p35 phosphorylation site targeted  by PKCξ  
has a role in regulating the cleavage of p35. For this purpose, w e examined the susceptibility 
of the p35-S33A mutant to calpain-mediated cleavage by inducing calpain activity in 
transfected  C2C12 myoblasts in the presence of  the calcium ionophore A23187. Western blot 
analysis of transfected  cells treated  or not with the calcium ionophore showed a significant 
decrease in the cleavage of the transfected  mutant p35-S33A when compared  to the wild  type 
p35 (III, Fig. 8A). Moreover, the comparison of the generation of the p25 fragment from cells 
overexpressing the wt p35 and cells overexpressing the mutant p35-S33A indicated  that the 
phosphorylation of this site is important to allow the calpain -mediated  cleavage of p35. 
Furthermore, in an  in vitro cleavage assay the pre-incubation of the Cdk5/ p35 complex with 
recombinant PKCξ  enhanced calpain-mediated  cleavage of p35 regardless of Cdk5 activity , 
confirming that PKCξ -mediated  phosphorylation of p35 plays a promoting role in the 
formation of the p25 fragment (III, Fig. 8B). Overall, these results suggest that upon 
differentiation PKCξ  interacts and  phosphorylates p35 on serine 33, thereby facilitating the 
calpain-mediated  cleavage into the more active form p25.  
 
In summary, we have identified  PKCξ  as a regulator of myoblast d ifferentiation through 
targeting of the Cdk5/ p35 complex (Figure 7). Even though PKCξ  deficient mice are viable 
and available for research studies, there are no reports about the involvement of PKCξ  in 
muscle development. In fact, mouse models for PKCξ  and Cdk5 have been characterized 
only for lymphoid  organs (Leitges et al., 2001; P. Martin et al., 2002) and the CNS (Ohshima 
et al., 1996, 1999). The involvement of the aPKC subfamily in cellular differentiation has been 
explored  in a neuronal cell model study showing that PKCι  is a downstream target of PI3K 
and Src kinase and is necessary to allow nerve growth factor (NGF)-mediated  induction of 
PC12 neuronal d ifferentiation (Wooten, Seibenhener, Neid igh, & Vandenplas, 2000), and  in a 
hematopoietic cell model study showing that PKCζ  promotes erythroid  d ifferentiation of 
human monocytic U937 leukaemic cells (Mansat-De Mas et al., 2002). More recently, 
pharmacological or siRNA-based  inhibition of PKCξ  in myoblasts were shown to affect 
multiple phases of d ifferentiation, including proliferation, migration and d ifferentiation  
progression (Odemis, Boosmann, Dieterlen, & Engele, 2007). Moreover, PKCξ  is essential in 
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regulating polarization and d ifferentiation of mammary acinus ephitelial cells (Whyte et al., 
2010) and to be critical in the self-renewal and commitment  to tissue-specific d ifferentiation 
of embryonic stem cells (Dutta et al., 2011). However, the likely compensatory role of the 
other aPKC, the ubiquitously expressed  PKC ι  should  be considered  for in vivo studies of 
muscle development in the PKCξ  deficient mice. Here we show that the cleavage and 
activation of the Cdk5 activator, p35 during myoblast differentiation  is dependent on both 
PKCξ  and calpain activities. We provide evidence for PKCξ  function ing both by d irect 
enhancement of calpain activities and  by phosphorylating p35 into a calpain cleavage-
permissive form. The prominent role played by PKCξ  in myoblast d ifferentiation, suggests 
an involvement of this kinase at m ultiple steps of this complex process. Moreover, the 
importance of both Cdk5 and PKCξ  in regulating neuronal d ifferentiation and homeostasis 
make the d iscovery of the signaling complex PKCξ / Cdk5/ p35 of interest for further studies 
and characterization in neurodegenerative diseases.  
 
 
 
 
 
 
 
Figure 7. Schematic model depicting the role of PKCζ  in myoblast differentiation. PKCζ  
phosphorylates and  activates calpains on one side and  phosphorylates p  35 on Ser33 which allows for 
calpain-mediated  cleavage of p35 on the other side. p35 cleavage is responsible for the increase in 
Cdk5 activity and  relocalization of the complex Cdk5/ p25 into the nucleus.   
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CONCLUDING REMARKS 
 
The final outcome of the activation of a stress sensor is highly dependent on the cellular 
protein composition, and  on the type and intensity of the stress. Stress signals are 
transmitted  through a limited  number of enzymatic stress pathways which have been 
optimized  during evolution to allow a more d iversified , fine-tuned and efficient response. 
The identification of a key player within a stress pathway and the mapping of its crosstalk 
potential with the neighbouring pathways is of obvious importance. 
 
In this thesis, I identified  in AATF a novel regulator of the AP-1 transcription factor c-Jun. 
The JNK-c-Jun pathway is a well-known mediator of cell adaptation to many environmental 
stresses and oncogenic transformation which are found regulating stress responses and 
d ifferentiation in all branches of eukaryotes. For decades, JNK-mediated  phosphorylation 
has been a dogma to explain c-Jun transcriptional activation. Yet phosphorylation -
independent functions of c-Jun have been reported , but these have remained poorly 
understood. Here I identify in  AATF a JNK-independent activator of c-Jun transcriptional 
activity, and  show that AATF is required  for c-Jun-mediated  apoptosis and  for the induction 
of the pro-apoptotic c-Jun target genes FasL and  Tnfα. Importantly I show that AATF is a 
nucleolar protein which shuttles into the nucleus upon UV irradiation or HDAC 
overexpression. Asymmetric subcellular d istribution of protein s is an excellent tool to 
increase the variability in composition and consequent function of multiprotein signaling 
complexes and evolved in parallel to the increase in cellular compartmentalization. The 
nucleolus is an ideal nuclear structure to store stress regulators as these can be rapid ly 
released  to transcription factor targets mediating a stress response, while adapting ribosomal 
production and cell growth to the sensed  stress and to cellular energy supplies levels. Indeed 
yeast homologous AATF is a nucleolar protein involved both in  stress response and 
ribosomal production. Highly complex and d iverse stress response pathways have 
developed by increasingly complex multicellular organisms during evolution. Stress 
response pathways have optimized and d iversified  the mechanisms to sense environmental 
conditions and nutrient availability and respond with a rapid  but controlled  nucleolar 
release of key regulators to nuclear transcription factors, such as the here described  c-Jun. 
The release of AATF into the nucleus could  therefore be proportional to the stress levels and 
determine the magnitude of c-Jun-mediated  biological responses.  
 
Subcellular distribution of key signaling regulators is a critical aspect also in the second 
major topic of this thesis covering the induction of the differentiation process. All the studies 
of this PhD describe signaling regulators whose spatial d istribution is regulated  by specific 
stimuli and  associated to a d istinct protein function. Indeed, in the last article, I show that, 
upon induction of differentiation the signalling complex Cdk5/ p35 moves from the 
cytoplasm to the nucleus where it targets an unidentified  d ifferentiation key regulator.  The 
d ifferentiation process involves a massive redistribution of regulators and kinases which 
enable the resetting of the expression profile to the new cellula r phenotype and is mediated 
by an intense and targeted  protein destruction and synthesis to allow the shaping of the 
induced morphological and  functional phenotype. Among the myriad  proteins involved, we 
focused  in identifying the upstream regulator of the Cdk5/ p35 complex. We show that the 
atypical PKCξ  phosphorylation of p35 is necessary to allow calpain -mediated  cleavage of 
p35 and consequent increase in Cdk5 activity during d ifferentiation. Upon cleavage, the 
Cdk5/ p35 complex shuttles into the nucleus where Cdk5 plays a still unknown role during 
d ifferentiation. Cdk5/ p35 shuttling to the nucleus has been described  during an apoptosis 
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insult and  Cdk5 has been shown to phosphorylate and inhibit the pro -survival activity of 
MEF2. Interestingly MEF2 activity is essential also to regulate muscle d ifferentiation, 
suggesting one possible and probable candidate target of Cdk5 in the nucleus during 
d ifferentiation. Moreover, we also showed that PKCξ  phosphorylates and thereby regulates 
calpains activities during myoblast d ifferentiation, suggesting that PKCξ  may both select 
calpain cleavable targets by phosphorylating them and boost calpain activity. Indeed, the 
fact that PKCξ  phosphorylates both  calpains and their substrates suggest a plausible 
mechanism of regulation and selection of the substrates targeted  by this protease upon 
d istinct stimuli. 
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